Renal	O
interstitial	O
fibrosis	O
is	O
reduced	O
in	O
angiotensin	B-protein
II	I-protein
type	I-protein
1a	I-protein
receptor	I-protein
-deficient	O
mice	O
.	O

Unilateral	O
ureteral	O
obstruction	O
(	O
UUO	O
)	O
results	O
in	O
tubulointerstitial	O
fibrosis	O
of	O
the	O
affected	O
kidney	O
by	O
stimulating	O
the	O
renin-angiotensin	O
system	O
.	O

This	O
study	O
established	O
a	O
UUO	O
model	O
in	O
angiotensin	B-protein
type	I-protein
1a	I-protein
receptor	I-protein
(	O
AT1a	B-protein
)	O
deficient	O
(	O
mutant	O
)	O
mice	O
to	O
elucidate	O
the	O
role	O
of	O
angiotensin	B-protein
II	I-protein
through	O
AT1a	B-protein
on	O
the	O
fibrosis	O
of	O
the	O
obstructed	O
kidney	O
(	O
OBK	O
)	O
.	O

The	O
relative	O
volume	O
of	O
the	O
tubulointerstitium	O
was	O
measured	O
by	O
an	O
image	O
analyzer	O
;	O
deposition	O
of	O
collagen	B-protein
types	I-protein
III	I-protein
and	I-protein
IV	I-protein
and	O
monocyte	B-cell_type
/	O
macrophage	B-cell_type
infiltration	O
were	O
histologically	O
examined	O
using	O
specific	B-protein
antibodies	I-protein
.	O

Also	O
determined	O
were	O
the	O
mRNA	O
levels	O
of	O
transforming	B-protein
growth	I-protein
factor-beta	I-protein
by	O
Northern	O
blot	O
analysis	O
.	O

Nuclear	B-protein
factor-kappaB	I-protein
activity	O
was	O
assessed	O
by	O
gel	O
shift	O
assay	O
.	O

UUO	O
in	O
wild	O
mice	O
resulted	O
in	O
a	O
marked	O
expansion	O
of	O
relative	O
volume	O
of	O
the	O
tubulointerstitium	O
,	O
together	O
with	O
increased	O
deposition	O
of	O
collagen	B-protein
types	I-protein
III	I-protein
and	I-protein
IV	I-protein
and	O
number	O
of	O
infiltrated	O
monocytes	B-cell_type
/	O
macrophages	B-cell_type
in	O
the	O
interstitium	O
,	O
relative	O
to	O
sham-operated	O
mice	O
.	O

In	O
comparison	O
,	O
these	O
changes	O
were	O
significantly	O
lower	O
in	O
mutant	O
mice	O
with	O
UUO	O
.	O

The	O
mRNA	O
level	O
of	O
transforming	B-protein
growth	I-protein
factor-beta	I-protein
was	O
significantly	O
higher	O
in	O
the	O
OBK	O
of	O
wild	O
mice	O
with	O
UUO	O
compared	O
with	O
sham-operated	O
mice	O
.	O

In	O
contrast	O
,	O
the	O
increase	O
in	O
mRNA	O
level	O
in	O
the	O
OBK	O
of	O
mutant	O
mice	O
was	O
significantly	O
less	O
than	O
in	O
wild	O
mice	O
.	O

Finally	O
,	O
UUO	O
resulted	O
in	O
activation	O
of	O
nuclear	B-protein
factor-kappaB	I-protein
in	O
wild	O
mice	O
but	O
was	O
inhibited	O
in	O
the	O
OBK	O
of	O
mutant	O
mice	O
.	O

The	O
results	O
provide	O
direct	O
evidence	O
that	O
angiotensin	B-protein
II	I-protein
acting	O
via	O
the	O
AT1a	B-protein
plays	O
a	O
pivotal	O
role	O
in	O
the	O
development	O
of	O
tubulointerstitial	O
fibrosis	O
in	O
UUO	O
.	O

J	NULL
Am	NULL
Soc	NULL
Nephrol	NULL
12	NULL
;	NULL
317-325	NULL
,	NULL
2001	NULL
Renal	NULL
Interstitial	NULL
Fibrosis	NULL
Is	NULL
Reduced	NULL
in	NULL
Angiotensin	NULL
II	NULL
Type	NULL
la	NULL
Receptor-Deficient	NULL
Mice	NULL
MINORU	NULL
SATOH	NULL
,	NULL
*	NULL
NAOKI	NULL
KASHIHARA	NULL
,	NULL
!	NULL

YASUSHI	NULL
YAMASAKI	NULL
,	NULL
*	NULL
KEISUKE	NULL
MARUYAMA	NULL
,	NULL
*	NULL
KAZUNORI	NULL
OKAMOTO	NULL
,	NULL
*	NULL
YOUHEI	NULL
MAESHIMA	NULL
,	NULL
*	NULL
HITOSHI	NULL
SUGIYAMA	NULL
,	NULL
*	NULL
TAKESHI	NULL
SUGAYA	NULL
,	NULL
*	NULL
KAZUO	NULL
MURAKAMLI	NULL
,	NULL
*	NULL
and	NULL
HIROFUMI	NULL
MAKINO*®	NULL
*Department	NULL
of	NULL
Medicine	NULL
III	NULL
,	NULL
Okayama	NULL
University	NULL
Medical	NULL
School	NULL
,	NULL
Okayama	NULL
;	NULL
``	NULL
Division	NULL
of	NULL
Nephrology	NULL
,	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
Kawasaki	NULL
Medical	NULL
School	NULL
,	NULL
Kurashiki	NULL
;	NULL
*Discovery	NULL
Research	NULL
Laboratory	NULL
,	NULL
Tanabe	NULL
Seiyaku	NULL
Co.	NULL
,	NULL
Ltd.	NULL
,	NULL
Osaka	NULL
;	NULL
and	NULL
``	NULL
Institute	NULL
of	NULL
Applied	NULL
Biochemistry	NULL
,	NULL
Tsukuba	NULL
Advanced	NULL
Research	NULL
Alliance	NULL
,	NULL
University	NULL
of	NULL
Tsukuba	NULL
,	NULL
Ibaragi	NULL
,	NULL
Japan	NULL
.	NULL

Abstract	NULL
.	NULL

Unilateral	NULL
ureteral	NULL
obstruction	NULL
(	NULL
UUO	NULL
)	NULL
results	NULL
in	NULL
tubulointerstitial	NULL
fibrosis	NULL
of	NULL
the	NULL
affected	NULL
kidney	NULL
by	NULL
stimulating	NULL
the	NULL
renin-angiotensin	NULL
system	NULL
.	NULL

This	NULL
study	NULL
established	NULL
a	NULL
UUO	NULL
model	NULL
in	NULL
angiotensin	NULL
type	NULL
la	NULL
receptor	NULL
(	NULL
AT1la	NULL
)	NULL
deficient	NULL
(	NULL
mutant	NULL
)	NULL
mice	NULL
to	NULL
elucidate	NULL
the	NULL
role	NULL
of	NULL
angiotensin	NULL
II	NULL
through	NULL
AT1la	NULL
on	NULL
the	NULL
fibrosis	NULL
of	NULL
the	NULL
obstructed	NULL
kidney	NULL
(	NULL
OBK	NULL
)	NULL
.	NULL

The	NULL
relative	NULL
volume	NULL
of	NULL
the	NULL
tubulointerstitium	NULL
was	NULL
measured	NULL
by	NULL
an	NULL
image	NULL
analyzer	NULL
;	NULL
deposition	NULL
of	NULL
collagen	NULL
types	NULL
III	NULL
and	NULL
IV	NULL
and	NULL
monocyte/macrophage	NULL
infiltration	NULL
were	NULL
histologically	NULL
examined	NULL
using	NULL
specific	NULL
antibodies	NULL
.	NULL

Also	NULL
determined	NULL
were	NULL
the	NULL
mRNA	NULL
levels	NULL
of	NULL
transforming	NULL
growth	NULL
factor-B	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

Nuclear	NULL
factor-	NULL
«	NULL
B	NULL
activity	NULL
was	NULL
assessed	NULL
by	NULL
gel	NULL
shift	NULL
assay	NULL
.	NULL

UUO	NULL
in	NULL
wild	NULL
mice	NULL
resulted	NULL
in	NULL
a	NULL
marked	NULL
expansion	NULL
of	NULL
relative	NULL
volume	NULL
of	NULL
the	NULL
tubulointerstitium	NULL
,	NULL
together	NULL
with	NULL
increased	NULL
deposition	NULL
of	NULL
collagen	NULL
types	NULL
III	NULL
and	NULL
IV	NULL
and	NULL
number	NULL
of	NULL
infiltrated	NULL
monocytes/macrophages	NULL
in	NULL
the	NULL
interstitium	NULL
,	NULL
relative	NULL
to	NULL
sham-operated	NULL
mice	NULL
.	NULL

In	NULL
comparison	NULL
,	NULL
these	NULL
changes	NULL
were	NULL
significantly	NULL
lower	NULL
in	NULL
mutant	NULL
mice	NULL
with	NULL
UUO	NULL
.	NULL

The	NULL
mRNA	NULL
level	NULL
of	NULL
transforming	NULL
growth	NULL
factor-B	NULL
was	NULL
significantly	NULL
higher	NULL
in	NULL
the	NULL
OBK	NULL
of	NULL
wild	NULL
mice	NULL
with	NULL
UUO	NULL
compared	NULL
with	NULL
sham-operated	NULL
mice	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
increase	NULL
in	NULL
mRNA	NULL
level	NULL
in	NULL
the	NULL
OBK	NULL
of	NULL
mutant	NULL
mice	NULL
was	NULL
significantly	NULL
less	NULL
than	NULL
in	NULL
wild	NULL
mice	NULL
.	NULL

Finally	NULL
,	NULL
UUO	NULL
resulted	NULL
in	NULL
activation	NULL
of	NULL
nuclear	NULL
in	NULL
wild	NULL
mice	NULL
but	NULL
was	NULL
inhibited	NULL
in	NULL
the	NULL
OBK	NULL
of	NULL
mutant	NULL
mice	NULL
.	NULL

The	NULL
results	NULL
provide	NULL
direct	NULL
evidence	NULL
that	NULL
angiotensin	NULL
II	NULL
acting	NULL
via	NULL
the	NULL
AT	NULL
1a	NULL
plays	NULL
a	NULL
pivotal	NULL
role	NULL
in	NULL
the	NULL
development	NULL
of	NULL
tubulointerstitial	NULL
fibrosis	NULL
in	NULL
UUO	NULL
.	NULL

It	NULL
is	NULL
widely	NULL
recognized	NULL
that	NULL
progressive	NULL
renal	NULL
disease	NULL
is	NULL
accompanied	NULL
by	NULL
tubulointerstitial	NULL
changes	NULL
characterized	NULL
by	NULL
tubular	NULL
atrophy	NULL
,	NULL
increased	NULL
number	NULL
of	NULL
interstitial	NULL
fibroblasts	NULL
,	NULL
phenotypic	NULL
change	NULL
of	NULL
interstitial	NULL
cells	NULL
,	NULL
accumulation	NULL
of	NULL
matrix	NULL
pro-teins	NULL
,	NULL
and	NULL
interstitial	NULL
infiltrate	NULL
of	NULL
mononuclear	NULL
cells	NULL
.	NULL

Deterioration	NULL
of	NULL
renal	NULL
function	NULL
is	NULL
determined	NULL
to	NULL
a	NULL
large	NULL
extent	NULL
by	NULL
the	NULL
degree	NULL
of	NULL
tubulointerstitial	NULL
changes	NULL
rather	NULL
than	NULL
by	NULL
the	NULL
extent	NULL
of	NULL
histologic	NULL
changes	NULL
in	NULL
the	NULL
glomeruli	NULL
in	NULL
many	NULL
forms	NULL
of	NULL
glomerulonephritis	NULL
.	NULL

However	NULL
,	NULL
the	NULL
pathogenic	NULL
mechanisms	NULL
of	NULL
tubulointerstitial	NULL
changes	NULL
have	NULL
not	NULL
yet	NULL
been	NULL
elucidated	NULL
fully	NULL
.	NULL

Evidence	NULL
from	NULL
many	NULL
studies	NULL
suggests	NULL
that	NULL
common	NULL
pathogenic	NULL
mechanisms	NULL
exist	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
tubulointerstitial	NULL
changes	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Unilateral	NULL
ureteral	NULL
obstruction	NULL
(	NULL
UUO	NULL
)	NULL
is	NULL
a	NULL
well-established	NULL
experimental	NULL
model	NULL
of	NULL
progressive	NULL
tubulointerstitial	NULL
fibrosis	NULL
.	NULL

Received	NULL
April	NULL
22	NULL
,	NULL
1999	NULL
.	NULL

Accepted	NULL
June	NULL
22	NULL
,	NULL
2000	NULL
.	NULL

This	NULL
study	NULL
was	NULL
presented	NULL
in	NULL
part	NULL
at	NULL
the	NULL
29th	NULL
Annual	NULL
Meeting	NULL
of	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Nephrology	NULL
(	NULL
November	NULL
1996	NULL
,	NULL
New	NULL
Orleans	NULL
,	NULL
LA	NULL
)	NULL
and	NULL
has	NULL
been	NULL
published	NULL
in	NULL
abstract	NULL
form	NULL
(	NULL
J	NULL
Am	NULL
Soc	NULL
Nephrol	NULL
7	NULL
:	NULL
1764	NULL
,	NULL
1996	NULL
)	NULL
.	NULL

Correspondence	NULL
to	NULL
Dr.	NULL
Naoki	NULL
Kashihara	NULL
,	NULL
Division	NULL
of	NULL
Nephrology	NULL
,	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
Kawasaki	NULL
Medical	NULL
School	NULL
,	NULL
577	NULL
Matsushima	NULL
,	NULL
Kurashiki	NULL
,	NULL
701-0192	NULL
,	NULL
Japan	NULL
.	NULL

Phone	NULL
:	NULL
81-86-462-1111	NULL
;	NULL
Fax	NULL
:	NULL
81-86-464-1199	NULL
;	NULL
E-mail	NULL
:	NULL
kashinao	NULL
@	NULL
med.kawasaki-m.ac.jp	NULL
1046-6673/1202-0317	NULL
Journal	NULL
of	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Nephrology	NULL
Copyright	NULL
©	NULL
2001	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Nephrology	NULL
UUO	NULL
leads	NULL
to	NULL
changes	NULL
in	NULL
renal	NULL
hemodynamics	NULL
(	NULL
2,3	NULL
)	NULL
,	NULL
macrophage	NULL
infiltration	NULL
into	NULL
the	NULL
kidney	NULL
(	NULL
4	NULL
)	NULL
,	NULL
and	NULL
tubular	NULL
hypertrophy	NULL
and	NULL
interstitial	NULL
fibrosis	NULL
of	NULL
the	NULL
affected	NULL
kidney	NULL
(	NULL
5	NULL
)	NULL
.	NULL

The	NULL
renin	NULL
angiotensin	NULL
system	NULL
(	NULL
RAS	NULL
)	NULL
is	NULL
also	NULL
known	NULL
to	NULL
be	NULL
activated	NULL
in	NULL
the	NULL
setting	NULL
of	NULL
UUO	NULL
.	NULL

UUO	NULL
is	NULL
associated	NULL
with	NULL
increased	NULL
plasma	NULL
renin	NULL
activity	NULL
and	NULL
renal	NULL
renin	NULL
content	NULL
,	NULL
angiotensin-converting	NULL
enzyme	NULL
(	NULL
ACE	NULL
)	NULL
activity	NULL
,	NULL
and	NULL
angiotensin	NULL
II	NULL
(	NULL
Ang	NULL
II	NULL
)	NULL
concentration	NULL
in	NULL
the	NULL
experimental	NULL
kidney	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Ang	NULL
II	NULL
generated	NULL
by	NULL
RAS	NULL
seems	NULL
to	NULL
play	NULL
a	NULL
pivotal	NULL
role	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
interstitial	NULL
fibrosis	NULL
.	NULL

Ang	NULL
II	NULL
also	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
mediate	NULL
overexpression	NULL
of	NULL
transforming	NULL
growth	NULL
factor-B	NULL
(	NULL
TGF-B	NULL
)	NULL
gene	NULL
(	NULL
7	NULL
)	NULL
,	NULL
a	NULL
major	NULL
cytokine	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
extracellular	NULL
matrix	NULL
(	NULL
ECM	NULL
)	NULL
protein	NULL
synthesis	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
ACE	NULL
inhibitor	NULL
or	NULL
angiotensin	NULL
type	NULL
1	NULL
receptor	NULL
(	NULL
AT1l	NULL
)	NULL
antagonists	NULL
ameliorate	NULL
tubulointerstitial	NULL
fibrosis	NULL
in	NULL
the	NULL
rat	NULL
UUO	NULL
model	NULL
(	NULL
9,10	NULL
)	NULL
.	NULL

Ang	NULL
II	NULL
exerts	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
biologic	NULL
activities	NULL
through	NULL
different	NULL
types	NULL
of	NULL
receptors	NULL
.	NULL

There	NULL
are	NULL
at	NULL
least	NULL
two	NULL
major	NULL
angiotensin	NULL
receptors	NULL
:	NULL
ATI	NULL
(	NULL
11	NULL
)	NULL
and	NULL
type	NULL
2	NULL
receptor	NULL
(	NULL
AT2	NULL
)	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
AT1	NULL
has	NULL
been	NULL
performed	NULL
in	NULL
several	NULL
species	NULL
.	NULL

These	NULL
studies	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
two	NULL
subtypes	NULL
of	NULL
AT1l	NULL
:	NULL
ATla	NULL
and	NULL
AT1b	NULL
.	NULL

Sequence	NULL
analysis	NULL
of	NULL
these	NULL
subreceptors	NULL
showed	NULL
a	NULL
high	NULL
homology	NULL
in	NULL
the	NULL
coding	NULL
sequence	NULL
of	NULL
their	NULL
mRNA	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
functional	NULL
difference	NULL
between	NULL
these	NULL
subtypes	NULL
has	NULL
yet	NULL
to	NULL
be	NULL
elucidated	NULL
,	NULL
AT	NULL
1a	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
be	NULL
the	NULL
predominant	NULL
isoform	NULL
.	NULL

318	NULL
Journal	NULL
of	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Nephrology	NULL
To	NULL
elucidate	NULL
the	NULL
functional	NULL
importance	NULL
of	NULL
AT	NULL
la-mediated	NULL
signal	NULL
transduction	NULL
pathways	NULL
in	NULL
the	NULL
pathophysiology	NULL
of	NULL
renal	NULL
diseases	NULL
,	NULL
especially	NULL
tubulointerstitial	NULL
injury	NULL
,	NULL
we	NULL
established	NULL
ATla-deficient	NULL
(	NULL
mutant	NULL
)	NULL
mice	NULL
with	NULL
a	NULL
targeted	NULL
replacement	NULL
of	NULL
ATla	NULL
loci	NULL
by	NULL
the	NULL
lacZ	NULL
gene	NULL
(	NULL
14,15	NULL
)	NULL
.	NULL

Using	NULL
these	NULL
mice	NULL
,	NULL
we	NULL
determined	NULL
in	NULL
the	NULL
present	NULL
study	NULL
the	NULL
role	NULL
of	NULL
the	NULL
Ang	NULL
II-AT1a	NULL
system	NULL
in	NULL
the	NULL
pathophysiology	NULL
of	NULL
tubulointerstitial	NULL
injury	NULL
after	NULL
experimentally	NULL
induced	NULL
UUO	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
action	NULL
of	NULL
Ang	NULL
II	NULL
via	NULL
ATla	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
development	NULL
of	NULL
tubulointerstitial	NULL
fibrosis	NULL
with	NULL
UUO	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Experimental	NULL
Protocol	NULL
Female	NULL
C57BL/6	NULL
(	NULL
wild	NULL
)	NULL
mice	NULL
at	NULL
the	NULL
age	NULL
of	NULL
10	NULL
wk	NULL
,	NULL
weighing	NULL
20	NULL
to	NULL
22	NULL
g	NULL
,	NULL
and	NULL
female	NULL
mutant	NULL
mice	NULL
at	NULL
the	NULL
age	NULL
of	NULL
10	NULL
wk	NULL
,	NULL
weighing	NULL
25	NULL
to	NULL
35	NULL
g	NULL
,	NULL
were	NULL
used	NULL
in	NULL
these	NULL
experiments	NULL
.	NULL

With	NULL
the	NULL
mice	NULL
under	NULL
pentobarbital	NULL
anesthesia	NULL
,	NULL
the	NULL
left	NULL
ureter	NULL
was	NULL
ligated	NULL
with	NULL
4-0	NULL
silk	NULL
at	NULL
two	NULL
locations	NULL
and	NULL
cut	NULL
between	NULL
the	NULL
ligatures	NULL
to	NULL
prevent	NULL
retrograde	NULL
urinary	NULL
tract	NULL
infection	NULL
in	NULL
both	NULL
wild	NULL
(	NULL
#	NULL
=	NULL
14	NULL
)	NULL
and	NULL
mutant	NULL
mice	NULL
(	NULL
n	NULL
=	NULL
14	NULL
)	NULL
.	NULL

Mice	NULL
that	NULL
were	NULL
operated	NULL
on	NULL
were	NULL
killed	NULL
under	NULL
pentobarbital	NULL
anesthesia	NULL
2	NULL
(	NULL
7	NULL
=	NULL
5	NULL
)	NULL
,	NULL
5	NULL
(	NULL
n	NULL
=	NULL
5	NULL
)	NULL
,	NULL
and	NULL
10	NULL
(	NULL
n	NULL
=	NULL
4	NULL
)	NULL
d	NULL
after	NULL
UUO	NULL
.	NULL

Sham	NULL
operation	NULL
was	NULL
performed	NULL
in	NULL
both	NULL
wild	NULL
(	NULL
@	NULL
r	NULL
=	NULL
4	NULL
)	NULL
and	NULL
mutant	NULL
mice	NULL
(	NULL
r	NULL
=	NULL
4	NULL
)	NULL
;	NULL
mice	NULL
had	NULL
their	NULL
ureters	NULL
manipulated	NULL
but	NULL
not	NULL
ligated	NULL
.	NULL

Five	NULL
d	NULL
after	NULL
sham	NULL
operation	NULL
,	NULL
mice	NULL
were	NULL
killed	NULL
to	NULL
obtain	NULL
control	NULL
kidneys	NULL
.	NULL

The	NULL
experimental	NULL
protocol	NULL
was	NULL
approved	NULL
by	NULL
the	NULL
Ethics	NULL
Review	NULL
Committees	NULL
for	NULL
Animal	NULL
Experimentation	NULL
of	NULL
the	NULL
participating	NULL
institutions	NULL
.	NULL

Morphometric	NULL
Evaluation	NULL
of	NULL
Interstitial	NULL
Fibrosis	NULL
of	NULL
Renal	NULL
Cortex	NULL
Obstructed	NULL
kidneys	NULL
(	NULL
OBK	NULL
)	NULL
were	NULL
removed	NULL
,	NULL
sliced	NULL
axially	NULL
into	NULL
3-mm-thick	NULL
sections	NULL
,	NULL
fixed	NULL
in	NULL
10	NULL
%	NULL
buffered	NULL
formalin	NULL
,	NULL
and	NULL
embedded	NULL
in	NULL
paraffin	NULL
.	NULL

Paraffin	NULL
sections	NULL
(	NULL
4-pm	NULL
thick	NULL
)	NULL
were	NULL
stained	NULL
with	NULL
Azan-Mallory	NULL
stain	NULL
.	NULL

Blue-stained	NULL
interstitial	NULL
fibrotic	NULL
areas	NULL
were	NULL
assessed	NULL
by	NULL
using	NULL
an	NULL
image	NULL
analyzer	NULL
(	NULL
MCID	NULL
image	NULL
analyzer	NULL
,	NULL
Fuji	NULL
Film	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

Five	NULL
consecutive	NULL
fields	NULL
were	NULL
randomly	NULL
selected	NULL
in	NULL
renal	NULL
cortex	NULL
and	NULL
evaluated	NULL
at	NULL
X400	NULL
on	NULL
a	NULL
10	NULL
X	NULL
10	NULL
grid-imprinted	NULL
reticule	NULL
.	NULL

All	NULL
points	NULL
not	NULL
counted	NULL
within	NULL
tubular	NULL
cells	NULL
,	NULL
lumen	NULL
,	NULL
glomerulus	NULL
,	NULL
or	NULL
vascular	NULL
space	NULL
were	NULL
considered	NULL
interstitial	NULL
.	NULL

This	NULL
fraction	NULL
represented	NULL
the	NULL
relative	NULL
interstitial	NULL
volume	NULL
.	NULL

Results	NULL
were	NULL
expressed	NULL
as	NULL
percentage	NULL
of	NULL
the	NULL
measured	NULL
area	NULL
,	NULL
which	NULL
represented	NULL
the	NULL
interstitial	NULL
space	NULL
and	NULL
was	NULL
determined	NULL
as	NULL
the	NULL
relative	NULL
volume	NULL
(	NULL
Vv	NULL
)	NULL
of	NULL
the	NULL
interstitium	NULL
.	NULL

Immunohistochemical	NULL
Studies	NULL
Indirect	NULL
immunofluorescence	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
surgically	NULL
removed	NULL
kidney	NULL
specimens	NULL
were	NULL
immediately	NULL
snap-frozen	NULL
and	NULL
unfixed	NULL
cryostat	NULL
sections	NULL
(	NULL
4-um	NULL
thick	NULL
)	NULL
were	NULL
prepared	NULL
.	NULL

The	NULL
sections	NULL
were	NULL
washed	NULL
in	NULL
phosphate	NULL
buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
three	NULL
times	NULL
,	NULL
5	NULL
min	NULL
each	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
the	NULL
primary	NULL
antibody	NULL
in	NULL
PBS	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Rabbit	NULL
polyclonal	NULL
antibodies	NULL
against	NULL
type	NULL
III	NULL
collagen	NULL
(	NULL
LSL	NULL
Corp.	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
;	NULL
dilution	NULL
1:60	NULL
)	NULL
and	NULL
type	NULL
IV	NULL
collagen	NULL
(	NULL
LSL	NULL
Corp.	NULL
;	NULL
dilution	NULL
1:30	NULL
)	NULL
were	NULL
used	NULL
as	NULL
primary	NULL
antibodies	NULL
.	NULL

Each	NULL
section	NULL
was	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
PBS	NULL
and	NULL
incubated	NULL
with	NULL
the	NULL
second	NULL
antibody	NULL
in	NULL
PBS	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Fluorescence	NULL
isothiocyanate-conjugated	NULL
goat	NULL
anti-rabbit	NULL
IgG	NULL
(	NULL
Zymed	NULL
Laboratories	NULL
,	NULL
Inc.	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
;	NULL
dilution	NULL
1:80	NULL
)	NULL
was	NULL
used	NULL
as	NULL
the	NULL
second	NULL
antibody	NULL
.	NULL

After	NULL
the	NULL
section	NULL
was	NULL
washed	NULL
with	NULL
PBS	NULL
three	NULL
times	NULL
,	NULL
it	NULL
was	NULL
mounted	NULL
with	NULL
fluoromount-G.	NULL
Deposition	NULL
of	NULL
type	NULL
III	NULL
and	NULL
type	NULL
IV	NULL
collagens	NULL
in	NULL
the	NULL
tubulointerstitium	NULL
of	NULL
renal	NULL
cortex	NULL
was	NULL
assessed	NULL
semiquantitatively	NULL
by	NULL
fluorescence	NULL
microscopy	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
17	NULL
)	NULL
.	NULL

A	NULL
matrix	NULL
deposition	NULL
score	NULL
ranging	NULL
from	NULL
O	NULL
to	NULL
3	NULL
was	NULL
J	NULL
Am	NULL
Soc	NULL
Nephrol	NULL
12	NULL
;	NULL
317-325	NULL
,	NULL
2001	NULL
determined	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
intensity	NULL
and	NULL
distribution	NULL
of	NULL
type	NULL
III	NULL
and	NULL
type	NULL
IV	NULL
collagens	NULL
in	NULL
the	NULL
tubulointerstitium	NULL
:	NULL
0	NULL
,	NULL
no	NULL
change	NULL
;	NULL
1	NULL
,	NULL
mild	NULL
change	NULL
;	NULL
2	NULL
,	NULL
moderate	NULL
change	NULL
;	NULL
3	NULL
,	NULL
severe	NULL
change	NULL
.	NULL

The	NULL
matrix	NULL
score	NULL
was	NULL
determined	NULL
in	NULL
each	NULL
section	NULL
selected	NULL
at	NULL
random	NULL
and	NULL
more	NULL
than	NULL
40	NULL
fields	NULL
were	NULL
examined	NULL
under	NULL
X200	NULL
magnification	NULL
.	NULL

Identification	NULL
and	NULL
Quantitation	NULL
of	NULL
Infiltrating	NULL
Monocytes/Macrophages	NULL
Infiltration	NULL
of	NULL
monocytes/macrophages	NULL
was	NULL
examined	NULL
by	NULL
immuno-histochemistry	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
formalin-fixed	NULL
,	NULL
paraffin-embedded	NULL
sections	NULL
were	NULL
deparaffinized	NULL
,	NULL
and	NULL
endogenous	NULL
peroxidase	NULL
was	NULL
inactivated	NULL
with	NULL
0.3	NULL
%	NULL
hydrogen	NULL
peroxide	NULL
.	NULL

Sections	NULL
were	NULL
then	NULL
washed	NULL
in	NULL
PBS	NULL
three	NULL
times	NULL
,	NULL
5	NULL
min	NULL
each	NULL
,	NULL
preincubated	NULL
in	NULL
a	NULL
blocking	NULL
solution	NULL
(	NULL
10	NULL
%	NULL
goat	NULL
serum	NULL
in	NULL
PBS	NULL
)	NULL
for	NULL
30	NULL
min	NULL
,	NULL
washed	NULL
in	NULL
PBS	NULL
three	NULL
times	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
F4/80	NULL
(	NULL
Serotec	NULL
,	NULL
Oxford	NULL
,	NULL
England	NULL
;	NULL
dilution	NULL
1:100	NULL
)	NULL
as	NULL
the	NULL
primary	NULL
antibody	NULL
against	NULL
monocytes/macrophages	NULL
.	NULL

Control	NULL
sections	NULL
using	NULL
wild	NULL
OBK	NULL
sections	NULL
were	NULL
treated	NULL
similarly	NULL
but	NULL
without	NULL
addition	NULL
of	NULL
the	NULL
primary	NULL
antibody	NULL
.	NULL

Each	NULL
section	NULL
was	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
PBS	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
the	NULL
second	NULL
antibody	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Biotinylated	NULL
rabbit	NULL
anti-goat	NULL
IgG	NULL
(	NULL
Nichirei	NULL
Corp.	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
;	NULL
dilution	NULL
1:1000	NULL
)	NULL
was	NULL
used	NULL
as	NULL
the	NULL
second	NULL
antibody	NULL
.	NULL

After	NULL
the	NULL
sections	NULL
were	NULL
washed	NULL
with	NULL
PBS	NULL
three	NULL
times	NULL
,	NULL
they	NULL
were	NULL
placed	NULL
in	NULL
streptavidin	NULL
labeled	NULL
with	NULL
peroxidase	NULL
(	NULL
Nichirei	NULL
Corp.	NULL
)	NULL
.	NULL

They	NULL
were	NULL
placed	NULL
in	NULL
diaminobenzidine/hydrogen	NULL
peroxide	NULL
solution	NULL
,	NULL
counterstained	NULL
with	NULL
hematoxylin	NULL
,	NULL
dehydrated	NULL
,	NULL
and	NULL
enclosed	NULL
in	NULL
synthetic	NULL
resin	NULL
.	NULL

Monocyte/macrophage	NULL
infiltration	NULL
was	NULL
determined	NULL
by	NULL
counting	NULL
the	NULL
number	NULL
of	NULL
F4/80	NULL
positively	NULL
stained	NULL
cells	NULL
in	NULL
the	NULL
renal	NULL
cortex	NULL
.	NULL

The	NULL
number	NULL
of	NULL
F4/80-positive	NULL
cells	NULL
was	NULL
determined	NULL
in	NULL
20	NULL
randomly	NULL
selected	NULL
nonoverlapping	NULL
X200	NULL
fields	NULL
in	NULL
each	NULL
section	NULL
of	NULL
the	NULL
individual	NULL
mouse	NULL
renal	NULL
cortex	NULL
.	NULL

The	NULL
average	NULL
number	NULL
of	NULL
F4/80-positive	NULL
cells	NULL
from	NULL
three	NULL
separate	NULL
animals	NULL
was	NULL
calculated	NULL
and	NULL
averaged	NULL
.	NULL

RNA	NULL
Extraction	NULL
and	NULL
Northern	NULL
Hybridization	NULL
Analysis	NULL
Total	NULL
RNA	NULL
from	NULL
the	NULL
cortex	NULL
was	NULL
extracted	NULL
by	NULL
the	NULL
acid	NULL
guanidium	NULL
thiocyanate	NULL
phenol	NULL
chloroform	NULL
extraction	NULL
method	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
19	NULL
)	NULL
.	NULL

RNA	NULL
concentration	NULL
and	NULL
purity	NULL
were	NULL
determined	NULL
spec-trophotometrically	NULL
.	NULL

A	NULL
total	NULL
of	NULL
20	NULL
ug	NULL
of	NULL
RNA	NULL
was	NULL
run	NULL
on	NULL
0.8	NULL
%	NULL
agarose	NULL
6	NULL
%	NULL
formaldehyde	NULL
gels	NULL
.	NULL

RNA	NULL
integrity	NULL
was	NULL
verified	NULL
by	NULL
examination	NULL
of	NULL
288	NULL
and	NULL
188	NULL
ribosomal	NULL
bands	NULL
of	NULL
ethidium	NULL
bromide-stained	NULL
material	NULL
under	NULL
ultraviolet	NULL
light	NULL
.	NULL

The	NULL
RNA	NULL
was	NULL
then	NULL
transferred	NULL
onto	NULL
nylon	NULL
membranes	NULL
(	NULL
Hybond-N	NULL
;	NULL
Amersham	NULL
Life	NULL
Science	NULL
,	NULL
Buckinghamshire	NULL
,	NULL
England	NULL
)	NULL
by	NULL
capillary	NULL
action	NULL
and	NULL
fixed	NULL
by	NULL
ultraviolet	NULL
irradiation	NULL
.	NULL

Membranes	NULL
were	NULL
hybridized	NULL
with	NULL
a	NULL
cDNA	NULL
probe	NULL
coding	NULL
for	NULL
mouse	NULL
TGF-f	NULL
labeled	NULL
with	NULL
[	NULL
«	NULL
-	NULL
``	NULL
°P	NULL
]	NULL
dATP	NULL
by	NULL
random	NULL
primed	NULL
DNA	NULL
synthesis	NULL
.	NULL

Membranes	NULL
were	NULL
hybridized	NULL
in	NULL
a	NULL
solution	NULL
containing	NULL
1	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
7	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
,	NULL
0.5	NULL
M	NULL
NaHPO	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
ethylenediaminetetraacetate	NULL
(	NULL
EDTA	NULL
)	NULL
.	NULL

The	NULL
filter	NULL
was	NULL
then	NULL
exposed	NULL
to	NULL
x-ray	NULL
film	NULL
at	NULL
-80°C	NULL
for	NULL
1	NULL
to	NULL
7	NULL
d.	NULL
The	NULL
membrane	NULL
was	NULL
rehybridized	NULL
with	NULL
a	NULL
cDNA	NULL
probe	NULL
coding	NULL
for	NULL
glyceraldehyde	NULL
phosphate	NULL
dehydroge-nase	NULL
(	NULL
GAPDH	NULL
)	NULL
labeled	NULL
with	NULL
[	NULL
a-	NULL
``	NULL
°P	NULL
]	NULL
dATP	NULL
.	NULL

The	NULL
relative	NULL
intensity	NULL
of	NULL
autoradiograms	NULL
was	NULL
determined	NULL
by	NULL
scanning	NULL
densitometry	NULL
.	NULL

Results	NULL
were	NULL
expressed	NULL
as	NULL
the	NULL
ratio	NULL
of	NULL
optical	NULL
density	NULL
of	NULL
TGP-B	NULL
to	NULL
GAPDH	NULL
relative	NULL
to	NULL
baseline	NULL
control	NULL
kidneys	NULL
that	NULL
were	NULL
arbitrarily	NULL
assigned	NULL
a	NULL
value	NULL
of	NULL
1	NULL
.	NULL

Detection	NULL
of	NULL
Renal	NULL
ATla	NULL
and	NULL
ATIb	NULL
mRNA	NULL
Expression	NULL
First	NULL
,	NULL
cDNA	NULL
strand	NULL
was	NULL
synthesized	NULL
from	NULL
total	NULL
RNA	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
by	NULL
Moloney-murine	NULL
leukemia	NULL
virus	NULL
reverse	NULL
transcriptase	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
,	NULL
Little	NULL
Chalfont	NULL
,	NULL
England	NULL
)	NULL
with	NULL
random	NULL
hexamers	NULL
as	NULL
a	NULL
primer	NULL
.	NULL

ATla	NULL
,	NULL
AT1b	NULL
,	NULL
and	NULL
GAPDH	NULL
cDNA	NULL
were	NULL
amplified	NULL
by	NULL
J	NULL
Am	NULL
Soc	NULL
Nephrol	NULL
12	NULL
;	NULL
317-325	NULL
,	NULL
2001	NULL
AmpliTaq	NULL
DNA	NULL
polymerase	NULL
(	NULL
Applied	NULL
Biosystems	NULL
,	NULL
Foster	NULL
City	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

PCR	NULL
was	NULL
performed	NULL
using	NULL
35	NULL
cycles	NULL
for	NULL
ATla	NULL
and	NULL
GAPDH	NULL
,	NULL
each	NULL
cycle	NULL
consisting	NULL
of	NULL
30	NULL
s	NULL
at	NULL
94°C	NULL
,	NULL
45	NULL
s	NULL
at	NULL
60°C	NULL
,	NULL
and	NULL
60	NULL
s	NULL
at	NULL
72°C	NULL
.	NULL

For	NULL
AT1b	NULL
,	NULL
35	NULL
cycles	NULL
were	NULL
used	NULL
,	NULL
each	NULL
cycle	NULL
consisting	NULL
of	NULL
60	NULL
s	NULL
at	NULL
94°C	NULL
,	NULL
90	NULL
s	NULL
at	NULL
55°C	NULL
,	NULL
and	NULL
90	NULL
s	NULL
at	NULL
72°C	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
separated	NULL
on	NULL
0.8	NULL
%	NULL
agarose	NULL
gel	NULL
and	NULL
stained	NULL
with	NULL
ethidium	NULL
bromide	NULL
.	NULL

Preparation	NULL
of	NULL
Nuclear	NULL
Extracts	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
the	NULL
kidney	NULL
cortex	NULL
according	NULL
to	NULL
the	NULL
procedure	NULL
of	NULL
Asanuma	NULL
et	NULL
al	NULL
.	NULL

(	NULL
20	NULL
)	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
the	NULL
kidney	NULL
cortex	NULL
was	NULL
minced	NULL
and	NULL
suspended	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
TBS	NULL
buffer	NULL
(	NULL
25	NULL
mM	NULL
Tris-HCI	NULL
]	NULL
[	NULL
pH	NULL
7.4	NULL
]	NULL
,	NULL
130	NULL
mM	NULL
NaCl	NULL
,	NULL
and	NULL
5	NULL
mM	NULL
KCI	NULL
)	NULL
and	NULL
homogenized	NULL
for	NULL
20	NULL
strokes	NULL
in	NULL
a	NULL
glass	NULL
homogenizer	NULL
.	NULL

The	NULL
homogenates	NULL
were	NULL
centrifuged	NULL
at	NULL
7000	NULL
X	NULL
g	NULL
for	NULL
30	NULL
s	NULL
,	NULL
and	NULL
the	NULL
pellets	NULL
were	NULL
resuspended	NULL
with	NULL
1	NULL
ml	NULL
of	NULL
TBS	NULL
buffer	NULL
and	NULL
vortexed	NULL
for	NULL
10	NULL
s	NULL
followed	NULL
by	NULL
centrifugation	NULL
of	NULL
the	NULL
homogenates	NULL
at	NULL
5000	NULL
X	NULL
g	NULL
for	NULL
30	NULL
s.	NULL
The	NULL
pellets	NULL
were	NULL
suspended	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
10	NULL
mM	NULL
KCI	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
mM	NULL
ethyleneglycol-bis	NULL
(	NULL
B-aminoethyl	NULL
ether	NULL
)	NULL
-N	NULL
,	NULL
NV	NULL
'	NULL
-tetraacetic	NULL
acid	NULL
,	NULL
1	NULL
mM	NULL
phenyImethylsulfonyl	NULL
fluoride	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
[	NULL
DTT	NULL
]	NULL
)	NULL
and	NULL
chilled	NULL
on	NULL
ice	NULL
for	NULL
20	NULL
min	NULL
.	NULL

In	NULL
the	NULL
next	NULL
step	NULL
,	NULL
100	NULL
ul	NULL
of	NULL
10	NULL
%	NULL
Nonidet	NULL
P-40	NULL
was	NULL
added	NULL
and	NULL
vigorously	NULL
vortexed	NULL
for	NULL
15	NULL
s.	NULL
The	NULL
nuclear	NULL
fraction	NULL
was	NULL
precipitated	NULL
by	NULL
centrifugation	NULL
at	NULL
12,000	NULL
X	NULL
g	NULL
for	NULL
7	NULL
min	NULL
and	NULL
suspended	NULL
in	NULL
100	NULL
pl	NULL
of	NULL
buffer	NULL
B	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
400	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
ethyleneglycol-bis	NULL
(	NULL
B-aminoethyl	NULL
ether	NULL
)	NULL
-N	NULL
,	NULL
N	NULL
-tetraacetic	NULL
acid	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
)	NULL
.	NULL

The	NULL
mixture	NULL
was	NULL
left	NULL
on	NULL
ice	NULL
for	NULL
2	NULL
h	NULL
with	NULL
frequent	NULL
agitation	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
centrifugation	NULL
at	NULL
12,000	NULL
X	NULL
g	NULL
for	NULL
7	NULL
min	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
protein	NULL
assay	NULL
reagent	NULL
(	NULL
Bio-Rad	NULL
Laboratories	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Gel	NULL
Shift	NULL
Assay	NULL
To	NULL
detect	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
,	NULL
gel	NULL
shift	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Consensus	NULL
sequences	NULL
of	NULL
nuclear	NULL
factor-	NULL
«	NULL
B	NULL
(	NULL
NF-kB	NULL
)	NULL
oligodeoxynucleotide	NULL
(	NULL
ODN	NULL
)	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
5'-AGTTGAGGGGACTTTCCCAGGC-3	NULL
'	NULL
.	NULL

The	NULL
ODN	NULL
was	NULL
labeled	NULL
by	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
performed	NULL
with	NULL
15	NULL
pg	NULL
of	NULL
nuclear	NULL
extracts	NULL
in	NULL
a	NULL
binding	NULL
buffer	NULL
consisting	NULL
of	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
0.5	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
4	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
50	NULL
mg/ml	NULL
poly	NULL
[	NULL
dl-dC	NULL
]	NULL
.	NULL

Each	NULL
30-	NULL
pl	NULL
reaction	NULL
mixture	NULL
was	NULL
incubated	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
and	NULL
then	NULL
approximately	NULL
200,000	NULL
cpm	NULL
of	NULL
[	NULL
y°°P	NULL
]	NULL
-ATP-labeled	NULL
ODN	NULL
probe	NULL
was	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
mixture	NULL
and	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Samples	NULL
were	NULL
then	NULL
electrophoresed	NULL
on	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
containing	NULL
45	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
,	NULL
45	NULL
mM	NULL
sodium	NULL
acetate	NULL
,	NULL
2.5	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
EDTA	NULL
.	NULL

Electrophoresis	NULL
was	NULL
carried	NULL
out	NULL
for	NULL
2	NULL
h.	NULL
After	NULL
electrophoresis	NULL
,	NULL
the	NULL
gel	NULL
was	NULL
dried	NULL
and	NULL
autoradiographed	NULL
and	NULL
the	NULL
relative	NULL
intensity	NULL
of	NULL
autoradiograms	NULL
was	NULL
determined	NULL
by	NULL
scanning	NULL
densitometry	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
reaction	NULL
,	NULL
we	NULL
performed	NULL
competition	NULL
assay	NULL
with	NULL
50-	NULL
and	NULL
10-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
consensus	NULL
sequences	NULL
of	NULL
NF-KB	NULL
.	NULL

The	NULL
unlabeled	NULL
probes	NULL
were	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
10	NULL
min	NULL
before	NULL
the	NULL
reaction	NULL
of	NULL
the	NULL
labeled	NULL
probe	NULL
.	NULL

When	NULL
supershift	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
,	NULL
polyclonal	NULL
antibodies	NULL
against	NULL
p50	NULL
or	NULL
p65	NULL
were	NULL
added	NULL
to	NULL
the	NULL
extracts	NULL
30	NULL
min	NULL
before	NULL
the	NULL
labeled	NULL
probe	NULL
.	NULL

Each	NULL
experiment	NULL
was	NULL
performed	NULL
three	NULL
times	NULL
.	NULL

Statistical	NULL
Analyses	NULL
Data	NULL
,	NULL
shown	NULL
as	NULL
mean	NULL
+	NULL
SD	NULL
,	NULL
were	NULL
analyzed	NULL
by	NULL
the	NULL
unpaired	NULL
£	NULL
test	NULL
using	NULL
the	NULL
Macintosh	NULL
StatView	NULL
program	NULL
(	NULL
Hulinks	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

One-way	NULL
ANOVA	NULL
was	NULL
used	NULL
to	NULL
determine	NULL
the	NULL
significance	NULL
of	NULL
the	NULL
relative	NULL
volume	NULL
of	NULL
the	NULL
renal	NULL
interstitium	NULL
,	NULL
F4/80	NULL
cell	NULL
infiltration	NULL
,	NULL
type	NULL
UUO	NULL
in	NULL
ATia-Deficient	NULL
Mice	NULL
319	NULL
III	NULL
collagen	NULL
or	NULL
type	NULL
IV	NULL
collagen	NULL
matrix	NULL
score	NULL
,	NULL
and	NULL
results	NULL
of	NULL
Northern	NULL
blots	NULL
and	NULL
gel	NULL
shift	NULL
assay	NULL
.	NULL

P	NULL
<	NULL
0.05	NULL
denoted	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
statistically	NULL
significant	NULL
difference	NULL
.	NULL

Results	NULL
Expression	NULL
of	NULL
Renal	NULL
ATla	NULL
and	NULL
AT1b	NULL
mRNA	NULL
The	NULL
expression	NULL
of	NULL
ATla	NULL
and	NULL
AT1b	NULL
mRNA	NULL
was	NULL
detected	NULL
by	NULL
reverse	NULL
transcription-PCR	NULL
(	NULL
RT-PCR	NULL
)	NULL
.	NULL

ATla	NULL
mRNA	NULL
was	NULL
expressed	NULL
in	NULL
wild	NULL
mice	NULL
but	NULL
was	NULL
absent	NULL
in	NULL
mutant	NULL
mice	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

Renal	NULL
AT1lb	NULL
mRNA	NULL
expression	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
either	NULL
wild	NULL
or	NULL
mutant	NULL
mice	NULL
.	NULL

Morphology	NULL
of	NULL
the	NULL
Renal	NULL
Cortex	NULL
Figure	NULL
2	NULL
demonstrated	NULL
sections	NULL
of	NULL
the	NULL
renal	NULL
cortex	NULL
stained	NULL
with	NULL
Azan-Mallory	NULL
stain	NULL
.	NULL

In	NULL
sham-operated	NULL
mutant	NULL
mice	NULL
,	NULL
hypertrophy	NULL
of	NULL
juxtaglomerular	NULL
apparatus	NULL
and	NULL
focal	NULL
hypertrophy	NULL
of	NULL
intrarenal	NULL
artery	NULL
was	NULL
evident	NULL
compared	NULL
with	NULL
sham-operated	NULL
wild	NULL
mice	NULL
(	NULL
Figure	NULL
2	NULL
,	NULL
B	NULL
and	NULL
H	NULL
)	NULL
,	NULL
although	NULL
the	NULL
tubules	NULL
and	NULL
interstitium	NULL
were	NULL
normal	NULL
(	NULL
Figure	NULL
2	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Five	NULL
d	NULL
after	NULL
UUO	NULL
in	NULL
wild	NULL
mice	NULL
,	NULL
fibrous	NULL
material	NULL
and	NULL
monocyte	NULL
infiltration	NULL
increased	NULL
in	NULL
the	NULL
interstitial	NULL
space	NULL
.	NULL

Furthermore	NULL
,	NULL
thickening	NULL
of	NULL
the	NULL
tubular	NULL
basement	NULL
membrane	NULL
and	NULL
widening	NULL
of	NULL
the	NULL
interstitial	NULL
space	NULL
of	NULL
the	NULL
renal	NULL
cortex	NULL
were	NULL
noted	NULL
(	NULL
Figure	NULL
2	NULL
,	NULL
C	NULL
and	NULL
E	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
interstitial	NULL
space	NULL
in	NULL
the	NULL
mutant	NULL
mice	NULL
did	NULL
not	NULL
show	NULL
a	NULL
significant	NULL
increase	NULL
(	NULL
Figure	NULL
2D	NULL
)	NULL
.	NULL

The	NULL
prevalence	NULL
of	NULL
atrophic	NULL
tubules	NULL
as	NULL
a	NULL
result	NULL
of	NULL
UUO	NULL
was	NULL
prominent	NULL
(	NULL
Figure	NULL
2F	NULL
)	NULL
,	NULL
and	NULL
there	NULL
were	NULL
no	NULL
changes	NULL
in	NULL
the	NULL
glomeruli	NULL
of	NULL
either	NULL
the	NULL
OBK	NULL
or	NULL
the	NULL
contralateral	NULL
kidney	NULL
at	NULL
5	NULL
d	NULL
(	NULL
Figure	NULL
2	NULL
,	NULL
G	NULL
and	NULL
H	NULL
)	NULL
.	NULL

There	NULL
was	NULL
no	NULL
particular	NULL
change	NULL
in	NULL
renal	NULL
function	NULL
(	NULL
serum	NULL
creatinine	NULL
level	NULL
:	NULL
sham	NULL
0.22	NULL
+	NULL
0.05	NULL
to	NULL
UUO	NULL
after	NULL
5	NULL
d	NULL
0.25	NULL
+	NULL
0.06	NULL
mg/dl	NULL
)	NULL
.	NULL

Wild	NULL
Mutant	NULL
Positive	NULL
control	NULL
SHAM	NULL
-	NULL
DAY2	NULL
DAYS	NULL
SHAM	NULL
DAY2	NULL
DAYS	NULL
ATia	NULL
ATib	NULL
GAPDH	NULL
Figure	NULL
1	NULL
.	NULL

Angiotensin	NULL
type	NULL
la	NULL
receptor	NULL
(	NULL
AT1la	NULL
)	NULL
and	NULL
AT1b	NULL
mRNA	NULL
of	NULL
the	NULL
unilateral	NULL
ureteral	NULL
obstruction	NULL
(	NULL
UUO	NULL
)	NULL
model	NULL
in	NULL
wild	NULL
or	NULL
homozygous	NULL
mutant	NULL
mice	NULL
.	NULL

Reverse	NULL
transcription-PCR	NULL
of	NULL
the	NULL
cortex	NULL
mRNA	NULL
from	NULL
wild	NULL
or	NULL
homozygous	NULL
mutant	NULL
mice	NULL
after	NULL
sham	NULL
operation	NULL
,	NULL
2	NULL
and	NULL
5	NULL
d	NULL
after	NULL
UUO	NULL
.	NULL

Total	NULL
RNA	NULL
from	NULL
adrenal	NULL
gland	NULL
were	NULL
used	NULL
for	NULL
positive	NULL
control	NULL
.	NULL

320	NULL
Journal	NULL
of	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Nephrology	NULL
32	NULL
Iew	NULL
fall	NULL
purrs	NULL
ig	NULL
\	NULL
Figure	NULL
2	NULL
.	NULL

Renal	NULL
cortex	NULL
stained	NULL
with	NULL
Azan-Mallory	NULL
:	NULL
Wild	NULL
sham-operated	NULL
kidney	NULL
(	NULL
A	NULL
)	NULL
,	NULL
mutant	NULL
sham-operated	NULL
kidney	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
wild	NULL
obstructed	NULL
kidney	NULL
(	NULL
OBK	NULL
)	NULL
at	NULL
5	NULL
d	NULL
after	NULL
UUO	NULL
(	NULL
C	NULL
)	NULL
and	NULL
mutant	NULL
OBK	NULL
at	NULL
5	NULL
d	NULL
after	NULL
UUO	NULL
(	NULL
D	NULL
)	NULL
.	NULL

Wild	NULL
OBK	NULL
at	NULL
5	NULL
d	NULL
after	NULL
UUO	NULL
(	NULL
E	NULL
)	NULL
and	NULL
mutant	NULL
OBK	NULL
at	NULL
5	NULL
d	NULL
after	NULL
UUO	NULL
(	NULL
F	NULL
)	NULL
.	NULL

Glomeruli	NULL
stained	NULL
with	NULL
Azan-Mallory	NULL
:	NULL
Mutant	NULL
OBK	NULL
(	NULL
G	NULL
)	NULL
and	NULL
mutant	NULL
contralateral	NULL
kidney	NULL
(	NULL
H	NULL
)	NULL
at	NULL
5	NULL
d	NULL
after	NULL
UUO	NULL
.	NULL

Magnifications	NULL
:	NULL
X200	NULL
in	NULL
A	NULL
through	NULL
D	NULL
;	NULL
X400	NULL
in	NULL
E	NULL
through	NULL
H.	NULL
Morphometric	NULL
Analysis	NULL
of	NULL
Tubulointerstitial	NULL
Volume	NULL
The	NULL
volume	NULL
of	NULL
the	NULL
interstitial	NULL
fibrotic	NULL
area	NULL
relative	NULL
to	NULL
the	NULL
cortical	NULL
tubulointerstitial	NULL
area	NULL
was	NULL
expressed	NULL
as	NULL
the	NULL
volume	NULL
fraction	NULL
(	NULL
Vv	NULL
)	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

The	NULL
interstitial	NULL
volume	NULL
of	NULL
the	NULL
OBK	NULL
was	NULL
significantly	NULL
increased	NULL
at	NULL
2	NULL
and	NULL
5	NULL
d	NULL
of	NULL
UUO	NULL
in	NULL
wild	NULL
mice	NULL
.	NULL

In	NULL
the	NULL
mutant	NULL
mice	NULL
,	NULL
Vv	NULL
of	NULL
OBK	NULL
at	NULL
2	NULL
ds	NULL
was	NULL
significantly	NULL
less	NULL
than	NULL
in	NULL
wild	NULL
mice	NULL
(	NULL
11.2	NULL
+	NULL
1.5	NULL
%	NULL
versus	NULL
16.8	NULL
+	NULL
2.2	NULL
%	NULL
;	NULL
P	NULL
<	NULL
0.01	NULL
)	NULL
.	NULL

At	NULL
5	NULL
d	NULL
,	NULL
the	NULL
difference	NULL
between	NULL
the	NULL
two	NULL
groups	NULL
was	NULL
smaller	NULL
but	NULL
still	NULL
significant	NULL
(	NULL
26.2	NULL
+	NULL
8.3	NULL
%	NULL
versus	NULL
37.8	NULL
+	NULL
4.9	NULL
%	NULL
;	NULL
P	NULL
<	NULL
0.05	NULL
;	NULL
Figure	NULL
3	NULL
)	NULL
,	NULL
but	NULL
at	NULL
10	NULL
d	NULL
after	NULL
UUO	NULL
,	NULL
the	NULL
interstitial	NULL
volume	NULL
of	NULL
the	NULL
OBK	NULL
in	NULL
mutant	NULL
mice	NULL
was	NULL
increased	NULL
the	NULL
same	NULL
as	NULL
in	NULL
wild	NULL
mice	NULL
(	NULL
40.7	NULL
+	NULL
8.1	NULL
%	NULL
versus	NULL
41.1	NULL
+	NULL
7.9	NULL
%	NULL
)	NULL
.	NULL

No	NULL
significant	NULL
J	NULL
Am	NULL
Soc	NULL
Nephrol	NULL
12	NULL
;	NULL
317-325	NULL
,	NULL
2001	NULL
50	NULL
;	NULL
CG	NULL
+s	NULL
GC	NULL
L	NULL
§	NULL
40	NULL
``	NULL
0	NULL
4	NULL
30	NULL
[	NULL
0	NULL
9	NULL
*	NULL
0	NULL
a	NULL
20	NULL
[	NULL
\	NULL
_	NULL
>	NULL
_	NULL
>	NULL
»	NULL
10	NULL
[	NULL
SHAM	NULL
DAY2	NULL
DAY5	NULL
-	NULL
DAY10	NULL
Figure	NULL
3	NULL
.	NULL

Volume	NULL
fraction	NULL
(	NULL
Vv	NULL
)	NULL
of	NULL
the	NULL
tubulointerstitium	NULL
after	NULL
UUO	NULL
in	NULL
wild	NULL
and	NULL
homozygous	NULL
mutant	NULL
mice	NULL
.	NULL

Data	NULL
are	NULL
mean	NULL
+	NULL
SD	NULL
.	NULL

C	NULL
,	NULL
wild	NULL
mice	NULL
;	NULL
M	NULL
,	NULL
mutant	NULL
mice	NULL
.	NULL

n	NULL
=	NULL
4	NULL
for	NULL
each	NULL
sham-operated	NULL
group	NULL
;	NULL
n	NULL
=	NULL
5	NULL
for	NULL
each	NULL
group	NULL
at	NULL
days	NULL
2	NULL
and	NULL
5	NULL
;	NULL
n	NULL
=	NULL
4	NULL
for	NULL
each	NULL
group	NULL
at	NULL
day	NULL
10	NULL
.	NULL

*	NULL
,	NULL
P	NULL
<	NULL
0.005	NULL
compared	NULL
with	NULL
wild	NULL
,	NULL
day	NULL
2	NULL
;	NULL
**	NULL
,	NULL
P	NULL
<	NULL
0.01	NULL
compared	NULL
with	NULL
wild	NULL
,	NULL
day	NULL
5.	NULL
difference	NULL
was	NULL
observed	NULL
in	NULL
Vv	NULL
of	NULL
the	NULL
contralateral	NULL
kidney	NULL
between	NULL
the	NULL
two	NULL
groups	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Immunohistochemical	NULL
Analysis	NULL
Type	NULL
III	NULL
collagen	NULL
was	NULL
clear	NULL
stained	NULL
and	NULL
confined	NULL
to	NULL
the	NULL
renal	NULL
interstitial	NULL
space	NULL
in	NULL
control	NULL
wild	NULL
mice	NULL
.	NULL

In	NULL
OBK	NULL
of	NULL
wild	NULL
mice	NULL
at	NULL
5	NULL
d	NULL
,	NULL
interstitial	NULL
type	NULL
III	NULL
collagen	NULL
was	NULL
markedly	NULL
increased	NULL
in	NULL
the	NULL
interstitial	NULL
space	NULL
compared	NULL
with	NULL
sham-operated	NULL
kidneys	NULL
(	NULL
SOK	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
type	NULL
III	NULL
collagen	NULL
was	NULL
not	NULL
increased	NULL
in	NULL
mutant	NULL
mice	NULL
;	NULL
there	NULL
was	NULL
little	NULL
staining	NULL
of	NULL
type	NULL
III	NULL
collagen	NULL
in	NULL
the	NULL
interstitial	NULL
space	NULL
.	NULL

In	NULL
sham-operated	NULL
kidney	NULL
,	NULL
there	NULL
was	NULL
no	NULL
difference	NULL
between	NULL
wild	NULL
and	NULL
mutant	NULL
mice	NULL
(	NULL
Figure	NULL
4	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Increased	NULL
deposition	NULL
of	NULL
type	NULL
IV	NULL
collagen	NULL
at	NULL
5	NULL
d	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
OBK	NULL
in	NULL
wild	NULL
mice	NULL
.	NULL

In	NULL
mutant	NULL
mice	NULL
,	NULL
there	NULL
was	NULL
a	NULL
significantly	NULL
less	NULL
deposition	NULL
of	NULL
type	NULL
IV	NULL
collagen	NULL
in	NULL
OBK	NULL
at	NULL
5	NULL
d	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
wild	NULL
mice	NULL
(	NULL
Figure	NULL
4	NULL
,	NULL
C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

The	NULL
matrix	NULL
scores	NULL
for	NULL
interstitial	NULL
types	NULL
III	NULL
and	NULL
IV	NULL
collagen	NULL
expression	NULL
are	NULL
summarized	NULL
in	NULL
Table	NULL
1	NULL
.	NULL

Two	NULL
d	NULL
after	NULL
UUO	NULL
,	NULL
the	NULL
matrix	NULL
deposition	NULL
score	NULL
of	NULL
type	NULL
III	NULL
collagen	NULL
was	NULL
significantly	NULL
higher	NULL
in	NULL
wild	NULL
mice	NULL
than	NULL
in	NULL
SOK	NULL
of	NULL
wild	NULL
mice	NULL
.	NULL

However	NULL
,	NULL
no	NULL
such	NULL
increase	NULL
was	NULL
observed	NULL
in	NULL
mutant	NULL
mice	NULL
.	NULL

At	NULL
5	NULL
d	NULL
after	NULL
UUO	NULL
,	NULL
however	NULL
,	NULL
the	NULL
difference	NULL
between	NULL
wild	NULL
and	NULL
mutant	NULL
mice	NULL
became	NULL
smaller	NULL
but	NULL
was	NULL
still	NULL
significant	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
.	NULL

At	NULL
10	NULL
d	NULL
after	NULL
UUO	NULL
,	NULL
there	NULL
was	NULL
no	NULL
significant	NULL
difference	NULL
between	NULL
the	NULL
two	NULL
groups	NULL
.	NULL

For	NULL
matrix	NULL
deposition	NULL
score	NULL
of	NULL
type	NULL
IV	NULL
collagen	NULL
,	NULL
deposition	NULL
was	NULL
significantly	NULL
higher	NULL
2	NULL
d	NULL
after	NULL
UUO	NULL
in	NULL
the	NULL
wild	NULL
mice	NULL
compared	NULL
with	NULL
SOK	NULL
(	NULL
Table	NULL
1	NULL
;	NULL
P	NULL
<	NULL
0.01	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
increased	NULL
deposition	NULL
measured	NULL
at	NULL
the	NULL
same	NULL
day	NULL
in	NULL
mutant	NULL
mice	NULL
was	NULL
not	NULL
significant	NULL
relative	NULL
to	NULL
SOK	NULL
of	NULL
mutant	NULL
mice	NULL
.	NULL

Changes	NULL
at	NULL
days	NULL
5	NULL
and	NULL
10	NULL
in	NULL
both	NULL
groups	NULL
were	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
type	NULL
III	NULL
collagen	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

J	NULL
Am	NULL
Soc	NULL
Nephrol	NULL
12	NULL
;	NULL
317-325	NULL
,	NULL
2001	NULL
UUO	NULL
in	NULL
ATia-Deficient	NULL
Mice	NULL
321	NULL
1	NULL
&	NULL
8°	NULL
)	NULL
3	NULL
3	NULL
.	NULL

30	NULL
|	NULL
a	NULL
o	NULL
3	NULL
m¥	NULL
|	NULL
£	NULL
!	NULL

41	NULL
E	NULL
B	NULL
f	NULL
w	NULL
a	NULL
$	NULL
o	NULL
|	NULL
|°	NULL
§§	NULL
3	NULL
F	NULL
ee	NULL
©	NULL
``	NULL
good	NULL
d	NULL
3	NULL
5	NULL
_	NULL
|	NULL
§	NULL
=	NULL
C	NULL
g	NULL
40	NULL
|	NULL
g	NULL
o	NULL
od	NULL
3	NULL
1	NULL
,	NULL
|	NULL
aB	NULL
}	NULL
+1	NULL
+141	NULL
0	NULL
9	NULL
in	NULL
&	NULL
in	NULL
\D	NULL
9	NULL
{	NULL
E	NULL
é	NULL
2a	NULL
82	NULL
$	NULL
~	NULL
.	NULL

§	NULL
o_	NULL
u_	NULL
o	NULL
g	NULL
1	NULL
18	NULL
)	NULL
,	NULL
|	NULL
§§	NULL
%	NULL
4	NULL
%	NULL
)	NULL
$	NULL
7	NULL
40	NULL
|	NULL
e	NULL
oe	NULL
S	NULL
|	NULL
g	NULL
2	NULL
as	NULL
|	NULL
£1	NULL
+1	NULL
+1	NULL
|	NULL
4	NULL
,	NULL
=	NULL
n	NULL
o	NULL
<	NULL
a	NULL
2	NULL
o	NULL
>	NULL
9	NULL
<	NULL
0	NULL
~	NULL
8	NULL
Figure	NULL
4	NULL
.	NULL

Immunofluorescent	NULL
micrographs	NULL
of	NULL
OBK	NULL
stained	NULL
for	NULL
type	NULL
IV	NULL
a	NULL
o	NULL
O	NULL
-	NULL
l	NULL
ap	NULL
5	NULL
collagen	NULL
.	NULL

Wild	NULL
sham-operated	NULL
kidney	NULL
(	NULL
A	NULL
)	NULL
,	NULL
mutant	NULL
sham-operated	NULL
kid-	NULL
E	NULL
é	NULL
i	NULL
ney	NULL
(	NULL
B	NULL
)	NULL
,	NULL
wild	NULL
OBK	NULL
at	NULL
5	NULL
d	NULL
after	NULL
UUO	NULL
(	NULL
C	NULL
)	NULL
,	NULL
and	NULL
mutant	NULL
OBK	NULL
at	NULL
5	NULL
d	NULL
after	NULL
JS	NULL
g	NULL
a	NULL
9	NULL
,	NULL
S	NULL
go	NULL
L	NULL
;	NULL
UUO	NULL
(	NULL
D	NULL
)	NULL
.	NULL

Magnification	NULL
,	NULL
X200	NULL
.	NULL

o	NULL
g	NULL
€	NULL
fl	NULL
fl	NULL
fl	NULL
43	NULL
E	NULL
«	NULL
=	NULL
«	NULL
A	NULL
5	NULL
£	NULL
€	NULL
``	NULL
Elggan	NULL
)	NULL
if	NULL
g	NULL
o	NULL
o	NULL
-|	NULL
g	NULL
«	NULL
g	NULL
Monocyte/Macrophage	NULL
Infiltration	NULL
in	NULL
the	NULL
Interstitium	NULL
a	NULL
so	NULL
6	NULL
$	NULL
<	NULL
Mononuclear	NULL
cell	NULL
infiltrates	NULL
that	NULL
were	NULL
positive	NULL
for	NULL
F4/80	NULL
g	NULL
5	NULL
Q	NULL
Q	NULL
é	NULL
£2	NULL
were	NULL
observed	NULL
in	NULL
the	NULL
cortex	NULL
after	NULL
UUO	NULL
in	NULL
both	NULL
groups	NULL
(	NULL
Figure	NULL
8	NULL
To	NULL
|	NULL
6	NULL
o	NULL
g	NULL
3	NULL
85	NULL
5	NULL
)	NULL
.	NULL

In	NULL
wild	NULL
mice	NULL
at	NULL
5	NULL
d	NULL
,	NULL
there	NULL
was	NULL
an	NULL
infiltration	NULL
of	NULL
the	NULL
renal	NULL
8	NULL
g	NULL
B	NULL
Ll	NULL
ill	NULL
5	NULL
‘	NULL
s	NULL
g	NULL
cortex	NULL
by	NULL
F4/80-positive	NULL
nilonhocytes/hmacrophages	NULL
(	NULL
Figure	NULL
5C	NULL
)	NULL
q	NULL
:	NULL
-	NULL
2	NULL
23	NULL
a	NULL
;	NULL
{	NULL
é	NULL
G	NULL
In	NULL
contrast	NULL
,	NULL
there	NULL
was	NULL
no	NULL
significant	NULL
infiltrate	NULL
of	NULL
F4/80-positive	NULL
>	NULL
,	NULL
8	NULL
.	NULL
``	NULL

s	NULL
cells	NULL
in	NULL
the	NULL
renal	NULL
cortex	NULL
of	NULL
mutant	NULL
mice	NULL
after	NULL
UUO	NULL
(	NULL
Figure	NULL
5D	NULL
)	NULL
.	NULL

2	NULL
Tn	NULL
to	NULL
LJ	NULL
)	NULL
a	NULL
ﬁg	NULL
There	NULL
was	NULL
no	NULL
staining	NULL
of	NULL
F4/80	NULL
in	NULL
the	NULL
negative	NULL
control	NULL
section	NULL
E	NULL
g	NULL
o	NULL
g	NULL
g	NULL
g	NULL
<	NULL
3	NULL
e	NULL
(	NULL
Figure	NULL
5E	NULL
)	NULL
.	NULL

Results	NULL
of	NULL
quantitative	NULL
analysis	NULL
of	NULL
monocytes/	NULL
o	NULL
B	NULL
H	NULL
+1411	NULL
|	NULL
R4	NULL
4	NULL
mn	NULL
the	NULL
nikal	NULL
€	NULL
2P	NULL
|	NULL
mn	NULL
a	NULL
|	NULL
5g	NULL
macrophages	NULL
in	NULL
the	NULL
interstitium	NULL
are	NULL
shown	NULL
in	NULL
Figure	NULL
6	NULL
.	NULL

The	NULL
.g	NULL
8	NULL
|	NULL
in	NULL
a	NULL
8	NULL
4	NULL
|	NULL
u	NULL
$	NULL
E	NULL
number	NULL
of	NULL
monocytes/macrophages	NULL
in	NULL
the	NULL
interstitium	NULL
in-	NULL
g	NULL
-	NULL
-	NULL
oal	NULL
on	NULL
§	NULL
nig-creased	NULL
significantly	NULL
2	NULL
d	NULL
after	NULL
UUO	NULL
in	NULL
the	NULL
wild	NULL
mice	NULL
,	NULL
compared	NULL
``	NULL
5	NULL
3	NULL
gong	NULL
a_	NULL
|	NULL
§	NULL
8k	NULL
with	NULL
SOK	NULL
,	NULL
with	NULL
a	NULL
further	NULL
increase	NULL
at	NULL
5	NULL
d.	NULL
In	NULL
mutant	NULL
mice	NULL
,	NULL
a	NULL
3	NULL
o	NULL
a	NULL
$	NULL
g	NULL
g	NULL
“	NULL
g	NULL
E	NULL
although	NULL
the	NULL
number	NULL
of	NULL
these	NULL
cells	NULL
also	NULL
increased	NULL
at	NULL
days	NULL
2	NULL
and	NULL
5	NULL
{	NULL
0	NULL
fl	NULL
”	NULL
fl	NULL
”	NULL
fl	NULL
”	NULL
62	NULL
E	NULL
gg	NULL
5	NULL
,	NULL
the	NULL
counts	NULL
were	NULL
significantly	NULL
less	NULL
at	NULL
2	NULL
and	NULL
5	NULL
d	NULL
compared	NULL
with	NULL
<	NULL
A	NULL
B	NULL
o	NULL
b	NULL
<	NULL
€	NULL
o	NULL
3	NULL
5	NULL
B	NULL
the	NULL
wild	NULL
mice	NULL
(	NULL
52	NULL
and	NULL
44	NULL
%	NULL
of	NULL
wild	NULL
mice	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

é	NULL
a	NULL
a	NULL
d	NULL
2	NULL
é	NULL
in	NULL
g	NULL
a	NULL
;	NULL
5	NULL
>	NULL
C	NULL
§	NULL
G	NULL
Expression	NULL
of	NULL
TGF-B	NULL
mRNA	NULL
i..-	NULL
a	NULL
8	NULL
&	NULL
Figure	NULL
7	NULL
demonstrates	NULL
the	NULL
relative	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
&	NULL
5	NULL
&	NULL
5	NULL
;	NULL
o	NULL
o	NULL
a	NULL
g	NULL
g	NULL
5	NULL
<	NULL
J	NULL
TGF-B	NULL
mRNA	NULL
at	NULL
2	NULL
and	NULL
5	NULL
d	NULL
of	NULL
UUO	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

S	NULL
a	NULL
a	NULL
$	NULL
1	NULL
Ll	NULL
2	NULL
.	NULL

E	NULL
E	NULL
o	NULL
§	NULL
The	NULL
amount	NULL
of	NULL
TGF-B	NULL
mRNA	NULL
in	NULL
the	NULL
OBK	NULL
in	NULL
wild	NULL
mice	NULL
was	NULL
§	NULL
al	NULL
=	NULL
$	NULL
2	NULL
é	NULL
3	NULL
§	NULL
B	NULL
o	NULL
ham	NULL
!	NULL

larger	NULL
after	NULL
UUO	NULL
than	NULL
in	NULL
SOK	NULL
.	NULL

At	NULL
5	NULL
d	NULL
of	NULL
UUO	NULL
,	NULL
the	NULL
mRNA	NULL
A	NULL
C	NULL
o	NULL
o	NULL
E	NULL
f	NULL
“	NULL
level	NULL
was	NULL
3.41	NULL
+	NULL
0.41-fold	NULL
compared	NULL
with	NULL
sham-operated	NULL
mice	NULL
€	NULL
2	NULL
ﬁfe	NULL
f	NULL
g	NULL
g	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
mutant	NULL
mice	NULL
,	NULL
the	NULL
increase	NULL
in	NULL
TGF-B	NULL
§	NULL
n	NULL
.o	NULL
13	NULL
a	NULL
Z	NULL
a	NULL
E	NULL
mRNA	NULL
levels	NULL
was	NULL
blunted	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
TGF-B	NULL
mRNA	NULL
``	NULL
8	NULL
g	NULL
g	NULL
a	NULL
+	NULL
]	NULL
Egg	NULL
level	NULL
in	NULL
OBK	NULL
above	NULL
that	NULL
in	NULL
SOK	NULL
was	NULL
significantly	NULL
less	NULL
at	NULL
2	NULL
d	NULL
'	NULL
E	NULL
2	NULL
2	NULL
oa	NULL
E	NULL
§	NULL
§	NULL
2	NULL
z	NULL
(	NULL
39	NULL
%	NULL
,	NULL
P	NULL
<	NULL
0.01	NULL
)	NULL
and	NULL
5	NULL
d	NULL
(	NULL
43	NULL
%	NULL
,	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
.	NULL

$	NULL
4468	NULL
)	NULL
3	NULL
%	NULL
§	NULL
EZ	NULL
)	NULL
$	NULL
447	NULL
:	NULL
NF-KB	NULL
Activation	NULL
3	NULL
.9	NULL
g	NULL
g	NULL
°	NULL
E	NULL
5	NULL
g	NULL
é	NULL
3	NULL
In	NULL
wild	NULL
mice	NULL
,	NULL
UUO	NULL
increased	NULL
NF-KB	NULL
activity	NULL
after	NULL
2	NULL
and	NULL
5	NULL
d	NULL
§	NULL
E	NULL
9	NULL
8p	NULL
a	NULL
?	NULL

@	NULL
g	NULL
$	NULL
6	NULL
§	NULL
relative	NULL
to	NULL
that	NULL
in	NULL
SOK	NULL
(	NULL
Figure	NULL
8	NULL
)	NULL
.	NULL

It	NULL
increased	NULL
3.2-fold	NULL
at	NULL
2	NULL
d	NULL
E	NULL
2	NULL
§	NULL
§	NULL
g	NULL
E	NULL
é	NULL
”	NULL
5	NULL
:	NULL
i	NULL
,	NULL
and	NULL
5.5-fold	NULL
at	NULL
5	NULL
d.	NULL
In	NULL
contrast	NULL
,	NULL
in	NULL
mutant	NULL
mice	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
acti-	NULL
ns	NULL
5	NULL
>	NULL
o	NULL
«	NULL
g	NULL
g	NULL
8	NULL
8	NULL
vation	NULL
was	NULL
not	NULL
increased	NULL
at	NULL
2	NULL
d.	NULL
Even	NULL
at	NULL
5	NULL
d	NULL
of	NULL
UUO	NULL
,	NULL
the	NULL
degree	NULL
m	NULL
o	NULL
o	NULL
E	NULL
%	NULL
7:31	NULL
E	NULL
V	NULL
V	NULL
reaps	NULL
rane	NULL
-3	NULL
3	NULL
>	NULL
>	NULL
A	NULL
A	NULL
,	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
was	NULL
significantly	NULL
suppressed	NULL
compared	NULL
§	NULL
&	NULL
:	NULL
&	NULL
:	NULL
E	NULL
PP	NULL
9	NULL
?	NULL

BS	NULL
with	NULL
that	NULL
in	NULL
SOK	NULL
(	NULL
Figures	NULL
9	NULL
and	NULL
10	NULL
)	NULL
.	NULL

S	NULL
-e	NULL
322	NULL
Journal	NULL
of	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Nephrology	NULL
%	NULL
p	NULL
y	NULL
a	NULL
%	NULL
¥	NULL
t	NULL
a	NULL
``	NULL
ol	NULL
ix	NULL
spd	NULL
Lo	NULL
OK	NULL
]	NULL
(	NULL
as	NULL
9	NULL
[	NULL
``	NULL
bp	NULL
*	NULL
%	NULL
``	NULL
%	NULL
*	NULL
%	NULL
.	NULL

:	NULL
.	NULL

f	NULL
hos	NULL
4	NULL
A	NULL
)	NULL
S	NULL
oe	NULL
:	NULL
£	NULL
Skee	NULL
s	NULL
+	NULL
i	NULL
hat	NULL
®	NULL
y+	NULL
gow	NULL
t	NULL
pM	NULL
4	NULL
W	NULL
uy	NULL
f	NULL
>	NULL
a	NULL
Miret	NULL
feal	NULL
-	NULL
a	NULL
&	NULL
t	NULL
§	NULL
¢	NULL
Teo	NULL
t.	NULL
2	NULL
C9	NULL
p	NULL
a	NULL
”	NULL
Jul-	NULL
``	NULL
a	NULL
!	NULL

ﬂ	NULL
;	NULL
nt	NULL
m\	NULL
*	NULL
a	NULL
f	NULL
Boks	NULL
59	NULL
i	NULL
w	NULL
f	NULL
&	NULL
A	NULL
\o	NULL
<	NULL
I4	NULL
.	NULL

‘	NULL
$	NULL
.	NULL

r	NULL
f	NULL
D	NULL
C	NULL
*s	NULL
O8	NULL
CA	NULL
J	NULL
&	NULL
Figure	NULL
5	NULL
.	NULL

F4/80	NULL
staining	NULL
of	NULL
the	NULL
tubulointerstitium	NULL
after	NULL
UUO	NULL
in	NULL
wild	NULL
or	NULL
homozygous	NULL
mutant	NULL
mice	NULL
.	NULL

Wild-sham	NULL
operated	NULL
kidney	NULL
(	NULL
A	NULL
)	NULL
,	NULL
mu-tant-sham	NULL
operated	NULL
kidney	NULL
(	NULL
B	NULL
)	NULL
,	NULL
wild	NULL
OBK	NULL
at	NULL
5	NULL
days	NULL
after	NULL
UUO	NULL
(	NULL
C	NULL
)	NULL
and	NULL
mutant	NULL
OBK	NULL
at	NULL
5	NULL
days	NULL
after	NULL
UUO	NULL
(	NULL
D	NULL
)	NULL
.	NULL

Negative	NULL
control	NULL
staining	NULL
using	NULL
wild	NULL
OBK	NULL
section	NULL
are	NULL
shown	NULL
in	NULL
E.	NULL
Original	NULL
magnification	NULL
:	NULL
X400	NULL
.	NULL

Discussion	NULL
Previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
UUO	NULL
in	NULL
rats	NULL
resulted	NULL
in	NULL
tubulointerstitial	NULL
fibrosis	NULL
(	NULL
3,5,17,22	NULL
)	NULL
and	NULL
that	NULL
such	NULL
pathologic	NULL
changes	NULL
could	NULL
be	NULL
reduced	NULL
by	NULL
ACE	NULL
inhibitors	NULL
or	NULL
ATI	NULL
receptor	NULL
antagonists	NULL
(	NULL
10,17	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
reduced	NULL
angiotensinogen	NULL
expression	NULL
attenuated	NULL
renal	NULL
interstitial	NULL
fibrosis	NULL
as	NULL
a	NULL
result	NULL
of	NULL
UUO	NULL
in	NULL
mice	NULL
(	NULL
23	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
in	NULL
this	NULL
model	NULL
,	NULL
RAS	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
interstitial	NULL
fibrosis	NULL
.	NULL

The	NULL
physiologic	NULL
effects	NULL
of	NULL
Ang	NULL
II	NULL
within	NULL
the	NULL
kidney	NULL
are	NULL
mediated	NULL
primarily	NULL
by	NULL
the	NULL
AT	NULL
1	NULL
receptor	NULL
subtype	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
AT1	NULL
in	NULL
rat	NULL
and	NULL
mouse	NULL
has	NULL
been	NULL
further	NULL
subclassified	NULL
by	NULL
molecular	NULL
cloning	NULL
into	NULL
AT1a	NULL
and	NULL
AT1b	NULL
subtypes	NULL
(	NULL
13,25,26	NULL
)	NULL
,	NULL
which	NULL
show	NULL
94	NULL
%	NULL
homology	NULL
at	NULL
the	NULL
amino	NULL
acid	NULL
level	NULL
and	NULL
are	NULL
pharmacolog-ically	NULL
indistinguishable	NULL
from	NULL
each	NULL
other	NULL
(	NULL
13	NULL
)	NULL
.	NULL

A	NULL
complete	NULL
block	NULL
of	NULL
the	NULL
AT	NULL
la	NULL
receptor	NULL
is	NULL
present	NULL
in	NULL
ATla-deficient	NULL
mice	NULL
from	NULL
birth	NULL
;	NULL
thus	NULL
,	NULL
this	NULL
mouse	NULL
is	NULL
useful	NULL
for	NULL
investigating	NULL
the	NULL
specific	NULL
function	NULL
of	NULL
AT	NULL
la	NULL
.	NULL

Using	NULL
this	NULL
model	NULL
,	NULL
we	NULL
examined	NULL
in	NULL
this	NULL
study	NULL
the	NULL
role	NULL
of	NULL
the	NULL
Ang	NULL
II-AT1la	NULL
system	NULL
in	NULL
the	NULL
development	NULL
of	NULL
interstitial	NULL
fibrosis	NULL
.	NULL

First	NULL
,	NULL
we	NULL
demonstrated	NULL
a	NULL
lack	NULL
of	NULL
expression	NULL
of	NULL
AT	NULL
1b	NULL
in	NULL
this	NULL
mouse	NULL
by	NULL
RT-PCR	NULL
and	NULL
thus	NULL
confirmed	NULL
that	NULL
in	NULL
this	NULL
model	NULL
,	NULL
Ang	NULL
II	NULL
does	NULL
not	NULL
act	NULL
through	NULL
AT1b	NULL
.	NULL

J	NULL
Am	NULL
Soc	NULL
Nephrol	NULL
12	NULL
;	NULL
317-325	NULL
,	NULL
2001	NULL
Tok	NULL
80	NULL
;	NULL
G	NULL
0	NULL
3	NULL
0	NULL
60	NULL
[	NULL
(	NULL
O	NULL
P	NULL
8	NULL
40	NULL
|	NULL
[	NULL
a	NULL
»	NULL
)	NULL
*	NULL
co	NULL
<	NULL
F	NULL
|	NULL
20	NULL
|	NULL
SHAM	NULL
DAY2	NULL
DAYS	NULL
Figure	NULL
6	NULL
.	NULL

Number	NULL
of	NULL
infiltrating	NULL
F4/80-positive	NULL
cells	NULL
in	NULL
the	NULL
tubulointerstitium	NULL
of	NULL
the	NULL
UUO	NULL
model	NULL
in	NULL
wild	NULL
or	NULL
homozygous	NULL
mutant	NULL
mice	NULL
.	NULL

Data	NULL
are	NULL
mean	NULL
+	NULL
SD	NULL
.	NULL

0	NULL
,	NULL
wild	NULL
mice	NULL
;	NULL
M	NULL
,	NULL
mutant	NULL
mice	NULL
.	NULL

The	NULL
number	NULL
of	NULL
F4/80-positive	NULL
cells	NULL
per	NULL
X200	NULL
field	NULL
of	NULL
kidney	NULL
cortex	NULL
of	NULL
four	NULL
separate	NULL
OBK	NULL
was	NULL
counted	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
section	NULL
.	NULL

*	NULL
,	NULL
P	NULL
<	NULL
0.01	NULL
compared	NULL
with	NULL
wild	NULL
,	NULL
day	NULL
2	NULL
;	NULL
**	NULL
,	NULL
P	NULL
<	NULL
0.05	NULL
compared	NULL
with	NULL
wild	NULL
,	NULL
day	NULL
5	NULL
.	NULL

Wild	NULL
SHAM	NULL
DAY2	NULL
DAYS	NULL
Mutant	NULL
SHAM	NULL
-	NULL
DAY2	NULL
DAYS	NULL
ﬂ	NULL
”	NULL
.	NULL

%	NULL
“	NULL
te	NULL
wea	NULL
»	NULL
e	NULL
Grn	NULL
~~~	NULL
:	NULL
Figure	NULL
7	NULL
.	NULL

Transforming	NULL
growth	NULL
factor-B	NULL
(	NULL
TGF-	NULL
)	NULL
mRNA	NULL
of	NULL
UUO	NULL
model	NULL
in	NULL
wild	NULL
or	NULL
homozygous	NULL
mutant	NULL
mice	NULL
.	NULL

Northern	NULL
blots	NULL
of	NULL
the	NULL
cortex	NULL
and	NULL
inner	NULL
medulla	NULL
RNA	NULL
from	NULL
wild	NULL
or	NULL
homozygous	NULL
mutant	NULL
mice	NULL
after	NULL
sham	NULL
operation	NULL
,	NULL
2	NULL
and	NULL
5	NULL
d	NULL
after	NULL
UUO	NULL
.	NULL

A	NULL
total	NULL
of	NULL
20	NULL
ug	NULL
of	NULL
RNA	NULL
was	NULL
loaded	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

-	NULL
TGF-	NULL
g	NULL
Morphologic	NULL
examination	NULL
of	NULL
the	NULL
kidney	NULL
of	NULL
homozygous	NULL
mutant	NULL
mice	NULL
showed	NULL
hypertrophy	NULL
of	NULL
juxtaglomerular	NULL
apparatus	NULL
and	NULL
focal	NULL
hypertrophy	NULL
of	NULL
intrarenal	NULL
artery	NULL
.	NULL

Angiotensinogen-deficient	NULL
mice	NULL
and	NULL
ACE-deficient	NULL
mice	NULL
typically	NULL
develop	NULL
abnormal	NULL
kidney	NULL
with	NULL
atrophy	NULL
of	NULL
renal	NULL
papillae	NULL
and	NULL
renal	NULL
vascular	NULL
thickening	NULL
(	NULL
27,28	NULL
)	NULL
.	NULL

Unlike	NULL
these	NULL
mice	NULL
,	NULL
homozygous	NULL
mutant	NULL
mice	NULL
used	NULL
in	NULL
our	NULL
study	NULL
did	NULL
not	NULL
show	NULL
any	NULL
histologic	NULL
abnormalities	NULL
in	NULL
the	NULL
tubulointerstitium	NULL
of	NULL
the	NULL
renal	NULL
cortex	NULL
.	NULL

Our	NULL
results	NULL
showed	NULL
that	NULL
the	NULL
volume	NULL
fraction	NULL
(	NULL
Vv	NULL
)	NULL
of	NULL
the	NULL
cortical	NULL
interstitium	NULL
in	NULL
the	NULL
OBK	NULL
in	NULL
mutant	NULL
mice	NULL
was	NULL
significantly	NULL
less	NULL
than	NULL
in	NULL
wild	NULL
mice	NULL
.	NULL

After	NULL
2	NULL
d	NULL
of	NULL
UUO	NULL
,	NULL
wild	NULL
mice	NULL
showed	NULL
a	NULL
3.5-fold	NULL
increase	NULL
in	NULL
interstitial	NULL
volume	NULL
,	NULL
but	NULL
mutant	NULL
mice	NULL
showed	NULL
only	NULL
a	NULL
1.2-fold	NULL
increase	NULL
.	NULL

However	NULL
,	NULL
after	NULL
5	NULL
d	NULL
of	NULL
UUO	NULL
,	NULL
the	NULL
difference	NULL
in	NULL
Vv	NULL
between	NULL
two	NULL
groups	NULL
had	NULL
become	NULL
J	NULL
Am	NULL
Soc	NULL
Nephrol	NULL
12	NULL
;	NULL
317-325	NULL
,	NULL
2001	NULL
“	NULL
wink	NULL
.	NULL

*+	NULL
ut	NULL
0D	NULL
00°	NULL
ub	NULL
og	NULL
NF-	NULL
«	NULL
B	NULL
~+	NULL
e	NULL
Figure	NULL
8	NULL
.	NULL

Nuclear	NULL
factor-	NULL
«	NULL
B	NULL
(	NULL
NF-KB	NULL
)	NULL
activation	NULL
.	NULL

Gel	NULL
shift	NULL
assay	NULL
of	NULL
NE-	NULL
«	NULL
B	NULL
are	NULL
shown	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
wild	NULL
sham-operated	NULL
kidney	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
wild	NULL
OBK	NULL
after	NULL
2	NULL
d	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
wild	NULL
OBK	NULL
after	NULL
5	NULL
d	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
mutant	NULL
sham-operated	NULL
kidney	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
mutant	NULL
OBK	NULL
after	NULL
2	NULL
d	NULL
;	NULL
lane	NULL
6	NULL
,	NULL
mutant	NULL
OBK	NULL
after	NULL
5	NULL
d.	NULL
|_*k	NULL
Relative	NULL
density	NULL
to	NULL
SHAM	NULL
SHAM	NULL
-	NULL
DAY2	NULL
-	NULL
DAYS	NULL
Figure	NULL
9	NULL
.	NULL

Scanning	NULL
densitometry	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

The	NULL
relative	NULL
intensity	NULL
to	NULL
sham	NULL
groups	NULL
is	NULL
shown	NULL
.	NULL

Data	NULL
are	NULL
mean	NULL
+	NULL
SD	NULL
.	NULL

C	NULL
,	NULL
wild	NULL
mice	NULL
;	NULL
M	NULL
,	NULL
mutant	NULL
mice	NULL
.	NULL

n	NULL
=	NULL
4	NULL
for	NULL
each	NULL
sham-operated	NULL
group	NULL
;	NULL
n	NULL
=	NULL
5	NULL
for	NULL
each	NULL
group	NULL
at	NULL
days	NULL
2	NULL
and	NULL
5	NULL
.	NULL

*	NULL
,	NULL
P	NULL
<	NULL
0.005	NULL
compared	NULL
with	NULL
wild	NULL
,	NULL
day	NULL
2	NULL
;	NULL
**.P	NULL
<	NULL
0.01	NULL
compared	NULL
with	NULL
wild	NULL
,	NULL
day	NULL
5.	NULL
smaller	NULL
.	NULL

After	NULL
10	NULL
d	NULL
,	NULL
there	NULL
were	NULL
no	NULL
differences	NULL
between	NULL
wild	NULL
mice	NULL
and	NULL
mutant	NULL
mice	NULL
.	NULL

These	NULL
differences	NULL
in	NULL
the	NULL
early	NULL
and	NULL
late	NULL
pathologic	NULL
responses	NULL
to	NULL
UUO	NULL
might	NULL
be	NULL
due	NULL
to	NULL
different	NULL
mech-	NULL
UUO	NULL
in	NULL
ATia-Deficient	NULL
Mice	NULL
323	NULL
.	NULL

1	NULL
]	NULL
Super	NULL
Shift	NULL
NF-	NULL
«	NULL
B	NULL
4-	NULL
Free	NULL
Figure	NULL
10	NULL
.	NULL

Specificity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
wild	NULL
OBK	NULL
after	NULL
5	NULL
d	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
pretreated	NULL
with	NULL
50X	NULL
excess	NULL
cold	NULL
NF-	NULL
«	NULL
B	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
pretreated	NULL
with	NULL
10X	NULL
excess	NULL
cold	NULL
mutant	NULL
NF-	NULL
«	NULL
B	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
pretreated	NULL
with	NULL
anti-p60	NULL
antibody	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
pretreated	NULL
with	NULL
anti-p50	NULL
antibody	NULL
.	NULL

anisms	NULL
inducing	NULL
these	NULL
changes	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
both	NULL
vitamin	NULL
E	NULL
(	NULL
29	NULL
)	NULL
,	NULL
an	NULL
antioxidant	NULL
,	NULL
and	NULL
arginine	NULL
(	NULL
30	NULL
)	NULL
,	NULL
which	NULL
increases	NULL
nitric	NULL
oxide	NULL
(	NULL
NO	NULL
)	NULL
produc-tion	NULL
,	NULL
improved	NULL
renal	NULL
tubulointerstitial	NULL
fibrosis	NULL
.	NULL

Reduced	NULL
production	NULL
of	NULL
intrarenal	NULL
NO	NULL
and	NULL
increased	NULL
production	NULL
of	NULL
reactive	NULL
oxygen	NULL
species	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
tubulointerstitial	NULL
fibrosis	NULL
process	NULL
,	NULL
which	NULL
is	NULL
characteristic	NULL
in	NULL
the	NULL
late	NULL
phase	NULL
in	NULL
the	NULL
UUO	NULL
model	NULL
.	NULL

Furthermore	NULL
,	NULL
because	NULL
of	NULL
the	NULL
lack	NULL
of	NULL
Ang	NULL
II-AT1a	NULL
system	NULL
in	NULL
our	NULL
mutant	NULL
mice	NULL
,	NULL
certain	NULL
compensatory	NULL
mechanisms	NULL
,	NULL
such	NULL
as	NULL
endothelin-1	NULL
(	NULL
1	NULL
)	NULL
,	NULL
might	NULL
explain	NULL
the	NULL
difference	NULL
in	NULL
the	NULL
late	NULL
and	NULL
early	NULL
phases	NULL
in	NULL
our	NULL
model	NULL
.	NULL

It	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
angiotensin	NULL
regulates	NULL
at	NULL
least	NULL
50	NULL
%	NULL
of	NULL
the	NULL
renal	NULL
interstitial	NULL
fibrotic	NULL
response	NULL
in	NULL
obstructive	NULL
nephropathy	NULL
using	NULL
mice	NULL
altering	NULL
the	NULL
number	NULL
of	NULL
copies	NULL
of	NULL
the	NULL
angiotensinogen	NULL
gene	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Immunohistochemical	NULL
studies	NULL
showed	NULL
less	NULL
deposition	NULL
of	NULL
types	NULL
III	NULL
and	NULL
IV	NULL
collagen	NULL
in	NULL
mutant	NULL
mice	NULL
relative	NULL
to	NULL
wild	NULL
mice	NULL
.	NULL

Type	NULL
IV	NULL
collagen	NULL
,	NULL
a	NULL
major	NULL
component	NULL
of	NULL
the	NULL
basement	NULL
mem-brane	NULL
,	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
thickened	NULL
tubular	NULL
basement	NULL
membrane	NULL
and	NULL
widened	NULL
interstitial	NULL
space	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
type	NULL
IV	NULL
collagen	NULL
in	NULL
the	NULL
interstitium	NULL
of	NULL
mutant	NULL
OBK	NULL
after	NULL
2	NULL
d	NULL
of	NULL
UUO	NULL
was	NULL
similar	NULL
to	NULL
the	NULL
sham-operated	NULL
mice	NULL
.	NULL

However	NULL
,	NULL
after	NULL
5	NULL
d	NULL
,	NULL
type	NULL
IV	NULL
collagen	NULL
deposition	NULL
increased	NULL
in	NULL
the	NULL
interstitial	NULL
space	NULL
to	NULL
a	NULL
level	NULL
similar	NULL
to	NULL
that	NULL
in	NULL
the	NULL
wild	NULL
mice	NULL
.	NULL

TGF-B	NULL
has	NULL
a	NULL
pleiotropic	NULL
effect	NULL
on	NULL
matrix	NULL
protein	NULL
production	NULL
.	NULL

TGF-	NULL
stimulates	NULL
gene	NULL
expression	NULL
of	NULL
ECM	NULL
components	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
showed	NULL
that	NULL
the	NULL
level	NULL
of	NULL
TGF-B	NULL
mRNA	NULL
was	NULL
increased	NULL
in	NULL
the	NULL
cortex	NULL
of	NULL
OBK	NULL
of	NULL
the	NULL
wild	NULL
mice	NULL
compared	NULL
with	NULL
SOK	NULL
.	NULL

This	NULL
finding	NULL
suggests	NULL
that	NULL
an	NULL
increased	NULL
level	NULL
of	NULL
TGF-	NULL
in	NULL
324	NULL
Journal	NULL
of	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Nephrology	NULL
the	NULL
cortex	NULL
augmented	NULL
the	NULL
synthesis	NULL
of	NULL
the	NULL
ECM	NULL
component	NULL
.	NULL

In	NULL
mutant	NULL
mice	NULL
,	NULL
a	NULL
UUO-induced	NULL
increase	NULL
in	NULL
the	NULL
level	NULL
of	NULL
TGF-B	NULL
mRNA	NULL
in	NULL
the	NULL
OBK	NULL
was	NULL
blunted	NULL
relative	NULL
to	NULL
wild	NULL
mice	NULL
,	NULL
suggesting	NULL
that	NULL
increased	NULL
levels	NULL
of	NULL
Ang	NULL
II	NULL
stimulate	NULL
gene	NULL
expression	NULL
of	NULL
TGF-	NULL
and	NULL
result	NULL
in	NULL
accumulation	NULL
of	NULL
ECM	NULL
.	NULL

Fern	NULL
et	NULL
al	NULL
.	NULL

(	NULL
23	NULL
)	NULL
also	NULL
showed	NULL
that	NULL
renal	NULL
expression	NULL
of	NULL
TGF-B	NULL
was	NULL
not	NULL
increased	NULL
by	NULL
UUO	NULL
in	NULL
mice	NULL
that	NULL
did	NULL
not	NULL
express	NULL
the	NULL
angiotensinogen	NULL
gene	NULL
.	NULL

ECM	NULL
might	NULL
accumulate	NULL
not	NULL
only	NULL
by	NULL
upregulation	NULL
of	NULL
its	NULL
synthesis	NULL
but	NULL
also	NULL
by	NULL
downregulation	NULL
of	NULL
its	NULL
degradation	NULL
.	NULL

ECM	NULL
proteins	NULL
are	NULL
degraded	NULL
by	NULL
various	NULL
proteinases	NULL
.	NULL

Among	NULL
these	NULL
,	NULL
the	NULL
plasmin	NULL
activator-plasmin	NULL
system	NULL
plays	NULL
a	NULL
major	NULL
role	NULL
.	NULL

Plasminogen	NULL
activator	NULL
inhibitor-1	NULL
inhibits	NULL
plasmin	NULL
activation	NULL
,	NULL
which	NULL
causes	NULL
ECM	NULL
storage	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
Ang	NULL
II	NULL
is	NULL
known	NULL
to	NULL
stimulate	NULL
the	NULL
production	NULL
of	NULL
TGF-B	NULL
and	NULL
plasminogen	NULL
activator	NULL
inhibitor-1	NULL
leading	NULL
to	NULL
a	NULL
rapid	NULL
matrix	NULL
accumulation	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Infiltration	NULL
of	NULL
monocytes/macrophages	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
renal	NULL
cortex	NULL
of	NULL
the	NULL
OBK	NULL
during	NULL
UUO	NULL
.	NULL

Ishidoya	NULL
et	NULL
al	NULL
.	NULL

(	NULL
10	NULL
)	NULL
reported	NULL
that	NULL
administration	NULL
of	NULL
ACE	NULL
inhibitor	NULL
but	NULL
not	NULL
Ang	NULL
II	NULL
receptor	NULL
antagonist	NULL
resulted	NULL
in	NULL
a	NULL
significant	NULL
reduction	NULL
in	NULL
the	NULL
number	NULL
of	NULL
infiltrating	NULL
monocytes/macrophages	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Lafayette	NULL
et	NULL
al	NULL
.	NULL

(	NULL
33	NULL
)	NULL
showed	NULL
that	NULL
ACE	NULL
and	NULL
ATI	NULL
blockade	NULL
resulted	NULL
in	NULL
similar	NULL
beneficial	NULL
effects	NULL
on	NULL
tissue	NULL
injury	NULL
after	NULL
subtotal	NULL
nephrectomy	NULL
.	NULL

In	NULL
another	NULL
study	NULL
,	NULL
Wu	NULL
et	NULL
al	NULL
.	NULL

(	NULL
34	NULL
)	NULL
demonstrated	NULL
that	NULL
treatment	NULL
with	NULL
both	NULL
drugs	NULL
reduced	NULL
the	NULL
infiltration	NULL
of	NULL
monocytes/macrophages	NULL
in	NULL
the	NULL
interstitium	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
the	NULL
number	NULL
of	NULL
monocytes/macrophages	NULL
in	NULL
the	NULL
OBK	NULL
of	NULL
mutant	NULL
mice	NULL
was	NULL
less	NULL
than	NULL
in	NULL
wild	NULL
mice	NULL
.	NULL

Several	NULL
chemoattrac-tants	NULL
for	NULL
monocyte/macrophage	NULL
infiltration	NULL
have	NULL
been	NULL
identi-fied	NULL
,	NULL
including	NULL
macrophage-colony	NULL
stimulant	NULL
factor	NULL
(	NULL
18	NULL
)	NULL
,	NULL
a	NULL
lipid	NULL
factor	NULL
(	NULL
35	NULL
)	NULL
,	NULL
monocyte	NULL
chemotactic	NULL
protein-1	NULL
(	NULL
MCP-1	NULL
)	NULL
(	NULL
36	NULL
)	NULL
,	NULL
and	NULL
osteopontin	NULL
(	NULL
37	NULL
)	NULL
.	NULL

MCP-1	NULL
gene	NULL
transcription	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
several	NULL
reports	NULL
have	NULL
indicated	NULL
the	NULL
possible	NULL
role	NULL
of	NULL
Ang	NULL
II	NULL
to	NULL
induce	NULL
NF-kB	NULL
activation	NULL
;	NULL
ACE	NULL
inhibitor	NULL
prevented	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
MCP-1	NULL
expression	NULL
,	NULL
and	NULL
macrophage	NULL
infiltration	NULL
in	NULL
a	NULL
rabbit	NULL
model	NULL
of	NULL
early	NULL
accelerated	NULL
arteriosclerosis	NULL
and	NULL
in	NULL
a	NULL
rat	NULL
model	NULL
of	NULL
immune	NULL
complex	NULL
nephritis	NULL
(	NULL
39,40	NULL
)	NULL
.	NULL

More	NULL
recent	NULL
,	NULL
Morrissey	NULL
and	NULL
Klahr	NULL
(	NULL
41	NULL
)	NULL
showed	NULL
that	NULL
ACE	NULL
inhibitor	NULL
decreased	NULL
activation	NULL
in	NULL
OBK	NULL
.	NULL

We	NULL
also	NULL
showed	NULL
that	NULL
in	NULL
the	NULL
UUO	NULL
model	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
in	NULL
the	NULL
mutant	NULL
mice	NULL
was	NULL
lower	NULL
than	NULL
in	NULL
wild	NULL
mice	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
was	NULL
mediated	NULL
by	NULL
the	NULL
Ang	NULL
II-AT1a	NULL
system	NULL
in	NULL
renal	NULL
cortex	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
the	NULL
relative	NULL
volume	NULL
of	NULL
the	NULL
tubulointerstitium	NULL
was	NULL
significantly	NULL
increased	NULL
in	NULL
the	NULL
mouse	NULL
renal	NULL
cortex	NULL
of	NULL
the	NULL
OBK	NULL
at	NULL
2	NULL
or	NULL
5d	NULL
after	NULL
UUO	NULL
compared	NULL
with	NULL
SOK	NULL
.	NULL

This	NULL
expansion	NULL
was	NULL
due	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
deposition	NULL
of	NULL
type	NULL
III	NULL
collagen	NULL
and	NULL
type	NULL
IV	NULL
collagen	NULL
and	NULL
monocyte/	NULL
macrophage	NULL
infiltration	NULL
in	NULL
the	NULL
tubulointerstitium	NULL
.	NULL

We	NULL
also	NULL
showed	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
TGF-B	NULL
mRNA	NULL
and	NULL
NF-kB	NULL
activation	NULL
was	NULL
increased	NULL
in	NULL
OBK	NULL
.	NULL

In	NULL
the	NULL
mutant	NULL
mouse	NULL
,	NULL
the	NULL
increase	NULL
in	NULL
the	NULL
interstitial	NULL
volume	NULL
,	NULL
deposition	NULL
of	NULL
type	NULL
III	NULL
collagen	NULL
and	NULL
type	NULL
IV	NULL
collagen	NULL
,	NULL
the	NULL
number	NULL
of	NULL
infiltrating	NULL
monocytes/macrophages	NULL
in	NULL
the	NULL
tubulointerstitium	NULL
,	NULL
expression	NULL
of	NULL
TGF-B	NULL
mRNA	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
were	NULL
significantly	NULL
reduced	NULL
compared	NULL
with	NULL
the	NULL
wild	NULL
mice	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
Ang	NULL
II-AT1a	NULL
system	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
progression	NULL
of	NULL
tubulointerstitial	NULL
fibrosis	NULL
in	NULL
UUO	NULL
in	NULL
mice	NULL
.	NULL

J	NULL
Am	NULL
Soc	NULL
Nephrol	NULL
12	NULL
;	NULL
317-325	NULL
,	NULL
2001	NULL
References	NULL
1	NULL
.	NULL

Eddy	NULL
AA	NULL
:	NULL
Molecular	NULL
insights	NULL
into	NULL
renal	NULL
interstitial	NULL
fibrosis	NULL
.	NULL

J	NULL
Am	NULL
Soc	NULL
Nephrol	NULL
7	NULL
:	NULL
2495-2508	NULL
,	NULL
1996	NULL
2	NULL
.	NULL

Klahr	NULL
S	NULL
,	NULL
Harris	NULL
K	NULL
,	NULL
Purkerson	NULL
ML	NULL
:	NULL
Effects	NULL
of	NULL
obstruction	NULL
on	NULL
renal	NULL
functions	NULL
.	NULL

Pediatr	NULL
Nephrol	NULL
2	NULL
:	NULL
34-42	NULL
,	NULL
1988	NULL
3	NULL
.	NULL

Klahr	NULL
S	NULL
:	NULL
New	NULL
insights	NULL
into	NULL
the	NULL
consequences	NULL
and	NULL
mechanisms	NULL
of	NULL
renal	NULL
impairment	NULL
in	NULL
obstructive	NULL
nephropathy	NULL
.	NULL

Am	NULL
J	NULL
Kidney	NULL
Dis	NULL
18	NULL
:	NULL
689-699	NULL
,	NULL
1991	NULL
4	NULL
.	NULL

Schreiner	NULL
GF	NULL
,	NULL
Harris	NULL
KP	NULL
,	NULL
Purkerson	NULL
ML	NULL
,	NULL
Klahr	NULL
S	NULL
:	NULL
Immunolog-ical	NULL
aspects	NULL
of	NULL
acute	NULL
ureteral	NULL
obstruction	NULL
:	NULL
Immune	NULL
cell	NULL
infiltrate	NULL
in	NULL
the	NULL
kidney	NULL
.	NULL

Kidney	NULL
Int	NULL
34	NULL
:	NULL
487-493	NULL
,	NULL
1988	NULL
5	NULL
.	NULL

Klahr	NULL
S	NULL
,	NULL
Pukerson	NULL
ML	NULL
:	NULL
The	NULL
pathophysiology	NULL
of	NULL
obstructive	NULL
nephropathy	NULL
:	NULL
The	NULL
role	NULL
of	NULL
vasoactive	NULL
compounds	NULL
in	NULL
the	NULL
hemody-namic	NULL
and	NULL
structural	NULL
abnormalities	NULL
of	NULL
the	NULL
obstructed	NULL
kidney	NULL
.	NULL

Am	NULL
J	NULL
Kidney	NULL
Dis	NULL
23	NULL
;	NULL
219-223	NULL
,	NULL
1994	NULL
6	NULL
.	NULL

Pimentel	NULL
JJ	NULL
,	NULL
Montero	NULL
A	NULL
,	NULL
Wang	NULL
S	NULL
,	NULL
Yosipiv	NULL
I	NULL
,	NULL
el-Dahr	NULL
S	NULL
,	NULL
Martinez	NULL
MM	NULL
:	NULL
Sequential	NULL
changes	NULL
in	NULL
renal	NULL
expression	NULL
of	NULL
renin-angiotensin	NULL
system	NULL
genes	NULL
in	NULL
acute	NULL
unilateral	NULL
ureteral	NULL
obstruction	NULL
.	NULL

Kidney	NULL
Int	NULL
48	NULL
:	NULL
1247-1253	NULL
,	NULL
1995	NULL
7	NULL
.	NULL

Pimentel	NULL
JJ	NULL
,	NULL
Sundell	NULL
CL	NULL
,	NULL
Wang	NULL
S	NULL
,	NULL
Kopp	NULL
JB	NULL
,	NULL
Montero	NULL
A	NULL
,	NULL
Martinez	NULL
MM	NULL
:	NULL
Role	NULL
of	NULL
angiotensin	NULL
II	NULL
in	NULL
the	NULL
expression	NULL
and	NULL
regulation	NULL
of	NULL
transforming	NULL
growth	NULL
factor-beta	NULL
in	NULL
obstructive	NULL
nephropathy	NULL
.	NULL

Kidney	NULL
Int	NULL
48	NULL
:	NULL
1233-1246	NULL
,	NULL
1995	NULL
8	NULL
.	NULL

Kuncio	NULL
GS	NULL
,	NULL
Neilson	NULL
EG	NULL
,	NULL
Haverty	NULL
T	NULL
:	NULL
Mechanisms	NULL
of	NULL
tubulointerstitial	NULL
fibrosis	NULL
.	NULL

Kidney	NULL
Int	NULL
39	NULL
:	NULL
550-556	NULL
,	NULL
1991	NULL
9	NULL
.	NULL

Pimentel	NULL
JJ	NULL
,	NULL
Martinez	NULL
MM	NULL
,	NULL
Wilcox	NULL
JN	NULL
,	NULL
Wang	NULL
S	NULL
,	NULL
Luo	NULL
C	NULL
:	NULL
Regulation	NULL
of	NULL
renin-angiotensin	NULL
system	NULL
in	NULL
unilateral	NULL
ureteral	NULL
obstruction	NULL
.	NULL

Kidney	NULL
Int	NULL
44	NULL
:	NULL
390-400	NULL
,	NULL
1993	NULL
10	NULL
.	NULL

Ishidoya	NULL
S	NULL
,	NULL
Morrissey	NULL
J	NULL
,	NULL
McCracken	NULL
R	NULL
,	NULL
Reyes	NULL
A	NULL
,	NULL
Klahr	NULL
S	NULL
:	NULL
Angiotensin	NULL
II	NULL
receptor	NULL
antagonist	NULL
ameliorates	NULL
renal	NULL
tubulointerstitial	NULL
fibrosis	NULL
caused	NULL
by	NULL
unilateral	NULL
ureteral	NULL
obstruction	NULL
.	NULL

Kidney	NULL
Int	NULL
47	NULL
:	NULL
1285-1294	NULL
,	NULL
1995	NULL
11	NULL
.	NULL

Murphy	NULL
TJ	NULL
,	NULL
Alexander	NULL
RW	NULL
,	NULL
Griendling	NULL
KK	NULL
,	NULL
Runge	NULL
MS	NULL
,	NULL
Bernstein	NULL
KE	NULL
:	NULL
Isolation	NULL
of	NULL
a	NULL
cDNA	NULL
encoding	NULL
the	NULL
vascular	NULL
type-1	NULL
angiotensin	NULL
II	NULL
receptor	NULL
.	NULL

Nature	NULL
351	NULL
:	NULL
233-236	NULL
,	NULL
1991	NULL
12	NULL
.	NULL

Hein	NULL
L	NULL
,	NULL
Barsh	NULL
GS	NULL
,	NULL
Pratt	NULL
RE	NULL
,	NULL
Dzau	NULL
VJ	NULL
,	NULL
Kobilka	NULL
BK	NULL
:	NULL
Behavioural	NULL
and	NULL
cardiovascular	NULL
effects	NULL
of	NULL
disrupting	NULL
the	NULL
angiotensin	NULL
II	NULL
type-2	NULL
receptor	NULL
in	NULL
mice	NULL
.	NULL

Nature	NULL
377	NULL
:	NULL
744-747	NULL
,	NULL
1995	NULL
13	NULL
.	NULL

Iwai	NULL
N	NULL
,	NULL
Inagami	NULL
T	NULL
:	NULL
Identification	NULL
of	NULL
two	NULL
subtypes	NULL
in	NULL
the	NULL
rat	NULL
type	NULL
I	NULL
angiotensin	NULL
II	NULL
receptor	NULL
.	NULL

FEBS	NULL
Leif	NULL
298	NULL
:	NULL
257-260	NULL
,	NULL
1992	NULL
14	NULL
.	NULL

Sugaya	NULL
T	NULL
,	NULL
Nishimatsu	NULL
S	NULL
,	NULL
Tanimoto	NULL
K	NULL
,	NULL
Takimoto	NULL
E	NULL
,	NULL
Yamagishi	NULL
T	NULL
,	NULL
Imamura	NULL
K	NULL
,	NULL
Goto	NULL
S	NULL
,	NULL
Imaizumi	NULL
K	NULL
,	NULL
Hisada	NULL
Y	NULL
,	NULL
Otsuka	NULL
A	NULL
,	NULL
Uchida	NULL
H	NULL
,	NULL
Sugiura	NULL
M	NULL
,	NULL
Fukuta	NULL
K	NULL
,	NULL
Fukamizu	NULL
A	NULL
,	NULL
Murakami	NULL
K	NULL
:	NULL
Angiotensin	NULL
II	NULL
type	NULL
1a	NULL
receptor-deficient	NULL
mice	NULL
with	NULL
hypotension	NULL
and	NULL
hyper-reninemia	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
270	NULL
;	NULL
18719-18722	NULL
,	NULL
1995	NULL
15	NULL
.	NULL

Hisada	NULL
Y	NULL
,	NULL
Sugaya	NULL
T	NULL
,	NULL
Yamanouchi	NULL
M	NULL
,	NULL
Uchida	NULL
H	NULL
,	NULL
Fujimura	NULL
H	NULL
,	NULL
Sakurai	NULL
H	NULL
,	NULL
Fukamizu	NULL
A	NULL
,	NULL
Murakami	NULL
K	NULL
:	NULL
Angiotensin	NULL
II	NULL
plays	NULL
a	NULL
pathogenic	NULL
role	NULL
in	NULL
immune-mediated	NULL
renal	NULL
injury	NULL
in	NULL
mice	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
103	NULL
;	NULL
627-635	NULL
,	NULL
1999	NULL
16	NULL
.	NULL

Otsuka	NULL
F	NULL
,	NULL
Yamauchi	NULL
T	NULL
,	NULL
Kataoka	NULL
H	NULL
,	NULL
Mimura	NULL
Y	NULL
,	NULL
Ogura	NULL
T	NULL
,	NULL
Makino	NULL
H	NULL
:	NULL
Effects	NULL
of	NULL
chronic	NULL
inhibition	NULL
of	NULL
ACE	NULL
and	NULL
AT1	NULL
receptors	NULL
on	NULL
glomerular	NULL
injury	NULL
in	NULL
Dahl	NULL
salt-sensitive	NULL
rats	NULL
.	NULL

Am	NULL
J	NULL
Physiol	NULL
274	NULL
:	NULL
R1797-R1806	NULL
,	NULL
1998	NULL
17	NULL
.	NULL

Kaneto	NULL
H	NULL
,	NULL
Morrissey	NULL
J	NULL
,	NULL
McCracken	NULL
R	NULL
,	NULL
Reyes	NULL
A	NULL
,	NULL
Klahr	NULL
S	NULL
:	NULL
Enalapril	NULL
reduces	NULL
collagen	NULL
type	NULL
IV	NULL
synthesis	NULL
and	NULL
expansion	NULL
of	NULL
the	NULL
interstitium	NULL
in	NULL
the	NULL
obstructed	NULL
rat	NULL
kidney	NULL
.	NULL

Kidney	NULL
Int	NULL
45	NULL
:	NULL
1637-1647	NULL
,	NULL
1994	NULL
18	NULL
.	NULL

Matsuda	NULL
M	NULL
,	NULL
Shikata	NULL
K	NULL
,	NULL
Makino	NULL
H	NULL
,	NULL
Sugimoto	NULL
H	NULL
,	NULL
Ota	NULL
Z	NULL
:	NULL
Glomerular	NULL
expression	NULL
of	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
and	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
in	NULL
patients	NULL
with	NULL
various	NULL
forms	NULL
of	NULL
glomerulonephritis	NULL
.	NULL

Lab	NULL
Invest	NULL
75	NULL
:	NULL
403-412	NULL
,	NULL
1996	NULL
J	NULL
Am	NULL
Soc	NULL
Nephrol	NULL
12	NULL
;	NULL
317-325	NULL
,	NULL
2001	NULL
19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

Makino	NULL
H	NULL
,	NULL
Kashihara	NULL
N	NULL
,	NULL
Sugiyama	NULL
H	NULL
,	NULL
Kanao	NULL
K	NULL
,	NULL
Sekikawa	NULL
T	NULL
,	NULL
Okamoto	NULL
K	NULL
,	NULL
Maeshima	NULL
Y	NULL
,	NULL
Ota	NULL
Z	NULL
,	NULL
Nagai	NULL
R	NULL
:	NULL
Phenotypic	NULL
modulation	NULL
of	NULL
the	NULL
mesangium	NULL
reflected	NULL
by	NULL
contractile	NULL
proteins	NULL
in	NULL
diabe-tes	NULL
.	NULL

Diabetes	NULL
45	NULL
:	NULL
488-495	NULL
,	NULL
1996	NULL
Asanuma	NULL
M	NULL
,	NULL
Nishibayashi	NULL
S	NULL
,	NULL
Kondo	NULL
Y	NULL
,	NULL
Iwata	NULL
E	NULL
,	NULL
Tsuda	NULL
M	NULL
,	NULL
Ogawa	NULL
N	NULL
:	NULL
Effects	NULL
of	NULL
single	NULL
cyclosporin	NULL
A	NULL
pretreatment	NULL
on	NULL
pen-tylenetetrazol-induced	NULL
convulsion	NULL
and	NULL
on	NULL
TRE-binding	NULL
activity	NULL
in	NULL
the	NULL
rat	NULL
brain	NULL
.	NULL

Brain	NULL
Res	NULL
Mol	NULL
Brain	NULL
Res	NULL
33	NULL
:	NULL
29-36	NULL
,	NULL
1995	NULL
Maeshima	NULL
Y	NULL
,	NULL
Kashihara	NULL
N	NULL
,	NULL
Yasuda	NULL
T	NULL
,	NULL
Sugiyama	NULL
H	NULL
,	NULL
Sekikawa	NULL
T	NULL
,	NULL
Okamoto	NULL
K	NULL
,	NULL
Kanao	NULL
K	NULL
,	NULL
Watanabe	NULL
Y	NULL
,	NULL
Kanwar	NULL
YS	NULL
,	NULL
Makino	NULL
H	NULL
:	NULL
Inhibition	NULL
of	NULL
mesangial	NULL
cell	NULL
proliferation	NULL
by	NULL
E2F	NULL
decoy	NULL
oligodeoxynucleotide	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
101	NULL
:	NULL
2589-2597	NULL
,	NULL
1998	NULL
Gonzalez	NULL
AG	NULL
,	NULL
Vadillo	NULL
OF	NULL
,	NULL
Perez	NULL
TR	NULL
:	NULL
Experimental	NULL
diffuse	NULL
interstitial	NULL
renal	NULL
fibrosis	NULL
.	NULL

A	NULL
biochemical	NULL
approach	NULL
.	NULL

Lab	NULL
Invest	NULL
59	NULL
:	NULL
245-252	NULL
,	NULL
1988	NULL
Fern	NULL
RJ	NULL
,	NULL
Yesko	NULL
CM	NULL
,	NULL
Thornhill	NULL
BA	NULL
,	NULL
Kim	NULL
HS	NULL
,	NULL
Smithies	NULL
O	NULL
,	NULL
Chevalier	NULL
RL	NULL
:	NULL
Reduced	NULL
angiotensinogen	NULL
expression	NULL
attenuates	NULL
renal	NULL
interstitial	NULL
fibrosis	NULL
in	NULL
obstructive	NULL
nephropathy	NULL
in	NULL
mice	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
103	NULL
;	NULL
39-46	NULL
,	NULL
1999	NULL
Smith	NULL
D	NULL
,	NULL
Chiu	NULL
AT	NULL
,	NULL
Wong	NULL
PC	NULL
,	NULL
Herblin	NULL
WF	NULL
,	NULL
Timmermans	NULL
PB	NULL
:	NULL
Pharmacology	NULL
of	NULL
nonpeptide	NULL
angiotensin	NULL
II	NULL
receptor	NULL
antagonists	NULL
.	NULL

Annu	NULL
Rev	NULL
Pharmacol	NULL
Toxicol	NULL
32	NULL
:	NULL
135-165	NULL
,	NULL
1992	NULL
Kakar	NULL
SS	NULL
,	NULL
Sellers	NULL
JC	NULL
,	NULL
Devor	NULL
DC	NULL
,	NULL
Musgrove	NULL
LC	NULL
,	NULL
Neill	NULL
JD	NULL
:	NULL
Angiotensin	NULL
II	NULL
type-1	NULL
receptor	NULL
subtype	NULL
cDNAs	NULL
:	NULL
Differential	NULL
tissue	NULL
expression	NULL
and	NULL
hormonal	NULL
regulation	NULL
.	NULL

Biochem	NULL
Biophys	NULL
Res	NULL
Commun	NULL
183	NULL
:	NULL
1090-1096	NULL
,	NULL
1992	NULL
Sandberg	NULL
K	NULL
,	NULL
Ji	NULL
H	NULL
,	NULL
Clark	NULL
AJ	NULL
,	NULL
Shapira	NULL
H	NULL
,	NULL
Catt	NULL
KJ	NULL
:	NULL
Cloning	NULL
and	NULL
expression	NULL
of	NULL
a	NULL
novel	NULL
angiotensin	NULL
II	NULL
receptor	NULL
subtype	NULL
.	NULL

J	NULL
Bio/	NULL
Chem	NULL
267	NULL
:	NULL
9455-9458	NULL
,	NULL
1992	NULL
Nagata	NULL
M	NULL
,	NULL
Tanimoto	NULL
K	NULL
,	NULL
Fukamizu	NULL
A	NULL
,	NULL
Kon	NULL
Y	NULL
,	NULL
Sugiyama	NULL
F	NULL
,	NULL
Yagami	NULL
K	NULL
,	NULL
Murakami	NULL
K	NULL
,	NULL
Watanabe	NULL
T	NULL
:	NULL
Nephrogenesis	NULL
and	NULL
renovascular	NULL
development	NULL
in	NULL
angiotensinogen-deficient	NULL
mice	NULL
.	NULL

Lab	NULL
Invest	NULL
75	NULL
:	NULL
745-1753	NULL
,	NULL
1996	NULL
Esther	NULL
CR	NULL
Jr	NULL
,	NULL
Howard	NULL
TE	NULL
,	NULL
Marino	NULL
EM	NULL
,	NULL
Goddard	NULL
JM	NULL
,	NULL
Capecchi	NULL
MR	NULL
,	NULL
Bernstein	NULL
KE	NULL
:	NULL
Mice	NULL
lacking	NULL
angiotensin-converting	NULL
enzyme	NULL
have	NULL
low	NULL
blood	NULL
pressure	NULL
,	NULL
renal	NULL
pathology	NULL
,	NULL
and	NULL
reduced	NULL
male	NULL
fertility	NULL
.	NULL

Lab	NULL
Invest	NULL
74	NULL
:	NULL
953-965	NULL
,	NULL
1996	NULL
Kuemmerle	NULL
NB	NULL
,	NULL
Brandt	NULL
RB	NULL
,	NULL
Chan	NULL
W	NULL
,	NULL
Krieg	NULL
RJ	NULL
Jr	NULL
,	NULL
Chan	NULL
JC	NULL
:	NULL
Inhibition	NULL
of	NULL
transforming	NULL
growth	NULL
factor	NULL
beta	NULL
1	NULL
induction	NULL
by	NULL
dietary	NULL
vitamin	NULL
E	NULL
in	NULL
unilateral	NULL
ureteral	NULL
obstruction	NULL
in	NULL
rats	NULL
.	NULL

Biochem	NULL
Mol	NULL
Med	NULL
61	NULL
:	NULL
82-86	NULL
,	NULL
1997	NULL
Morrissey	NULL
JJ	NULL
,	NULL
Ishidoya	NULL
S	NULL
,	NULL
McCracken	NULL
R	NULL
,	NULL
Klahr	NULL
S	NULL
:	NULL
Nitric	NULL
oxide	NULL
31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

UUO	NULL
in	NULL
ATia-Deficient	NULL
Mice	NULL
325	NULL
generation	NULL
ameliorates	NULL
the	NULL
tubulointerstitial	NULL
fibrosis	NULL
of	NULL
obstructive	NULL
nephropathy	NULL
.	NULL

J	NULL
Am	NULL
Soc	NULL
Nephrol	NULL
7	NULL
:	NULL
2202-2212	NULL
,	NULL
1996	NULL
Creely	NULL
JJ	NULL
,	NULL
DiMari	NULL
SJ	NULL
,	NULL
Howe	NULL
AM	NULL
,	NULL
Haralson	NULL
MA	NULL
:	NULL
Effects	NULL
of	NULL
transforming	NULL
growth	NULL
factor-beta	NULL
on	NULL
collagen	NULL
synthesis	NULL
by	NULL
normal	NULL
rat	NULL
kidney	NULL
epithelial	NULL
cells	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
140	NULL
:	NULL
45-55	NULL
,	NULL
1992	NULL
Matsusaka	NULL
T	NULL
,	NULL
Hymes	NULL
J	NULL
,	NULL
Ichikawa	NULL
I	NULL
:	NULL
Angiotensin	NULL
in	NULL
progressive	NULL
renal	NULL
diseases	NULL
:	NULL
Theory	NULL
and	NULL
practice	NULL
.	NULL

J	NULL
Am	NULL
Soc	NULL
Nephrol	NULL
7	NULL
:	NULL
2025-2043	NULL
,	NULL
1996	NULL
Lafayette	NULL
RA	NULL
,	NULL
Mayer	NULL
G	NULL
,	NULL
Park	NULL
SK	NULL
,	NULL
Meyer	NULL
TW	NULL
:	NULL
Angiotensin	NULL
II	NULL
receptor	NULL
blockade	NULL
limits	NULL
glomerular	NULL
injury	NULL
in	NULL
rats	NULL
with	NULL
reduced	NULL
renal	NULL
mass	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
90	NULL
:	NULL
766-771	NULL
,	NULL
1992	NULL
Wu	NULL
LL	NULL
,	NULL
Cox	NULL
A	NULL
,	NULL
Roe	NULL
CJ	NULL
,	NULL
Dziadek	NULL
M	NULL
,	NULL
Cooper	NULL
ME	NULL
,	NULL
Gilbert	NULL
RE	NULL
:	NULL
Transforming	NULL
growth	NULL
factor	NULL
beta	NULL
1	NULL
and	NULL
renal	NULL
injury	NULL
following	NULL
subtotal	NULL
nephrectomy	NULL
in	NULL
the	NULL
rat	NULL
:	NULL
Role	NULL
of	NULL
the	NULL
renin-angiotensin	NULL
system	NULL
.	NULL

Kidney	NULL
Int	NULL
51	NULL
:	NULL
1553-1567	NULL
,	NULL
1997	NULL
Rovin	NULL
BH	NULL
,	NULL
Harris	NULL
KP	NULL
,	NULL
Morrison	NULL
A	NULL
,	NULL
Klahr	NULL
S	NULL
,	NULL
Schreiner	NULL
GF	NULL
:	NULL
Renal	NULL
cortical	NULL
release	NULL
of	NULL
a	NULL
specific	NULL
macrophage	NULL
chemoattractant	NULL
in	NULL
response	NULL
to	NULL
ureteral	NULL
obstruction	NULL
.	NULL

Lab	NULL
Invest	NULL
63	NULL
:	NULL
213-220	NULL
,	NULL
1990	NULL
.	NULL

Diamond	NULL
JR	NULL
,	NULL
Kees	NULL
FD	NULL
,	NULL
Ding	NULL
G	NULL
,	NULL
Frye	NULL
JE	NULL
,	NULL
Restrepo	NULL
NC	NULL
:	NULL
Macro-phages	NULL
,	NULL
monocyte	NULL
chemoattractant	NULL
peptide-1	NULL
,	NULL
and	NULL
TGF-beta	NULL
1	NULL
in	NULL
experimental	NULL
hydronephrosis	NULL
.	NULL

Am	NULL
J	NULL
Physiol	NULL
F926-F933	NULL
,	NULL
1994	NULL
Pichler	NULL
R	NULL
,	NULL
Giachelli	NULL
CM	NULL
,	NULL
Lombardi	NULL
D	NULL
,	NULL
Pippin	NULL
J	NULL
,	NULL
Gordon	NULL
K	NULL
,	NULL
Alpers	NULL
CE	NULL
,	NULL
Schwartz	NULL
SM	NULL
,	NULL
Johnson	NULL
RJ	NULL
:	NULL
Tubulointerstitial	NULL
disease	NULL
in	NULL
glomerulonephritis	NULL
.	NULL

Potential	NULL
role	NULL
of	NULL
osteopontin	NULL
(	NULL
uropontin	NULL
)	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
144	NULL
;	NULL
915-926	NULL
,	NULL
1994	NULL
Rovin	NULL
BH	NULL
,	NULL
Dickerson	NULL
JA	NULL
,	NULL
Tan	NULL
LC	NULL
,	NULL
Hebert	NULL
CA	NULL
:	NULL
Activation	NULL
of	NULL
nuclear	NULL
factor-kappa	NULL
B	NULL
correlates	NULL
with	NULL
MCP-1	NULL
expression	NULL
by	NULL
human	NULL
mesangial	NULL
cells	NULL
.	NULL

Kidney	NULL
Int	NULL
48	NULL
:	NULL
1263-1271	NULL
,	NULL
1995	NULL
Hernandez	NULL
PM	NULL
,	NULL
Bustos	NULL
C	NULL
,	NULL
Ortego	NULL
M	NULL
,	NULL
Tunon	NULL
J	NULL
,	NULL
Renedo	NULL
G	NULL
,	NULL
Ruiz	NULL
OM	NULL
,	NULL
Egido	NULL
J	NULL
:	NULL
Angiotensin-converting	NULL
enzyme	NULL
inhibition	NULL
prevents	NULL
arterial	NULL
nuclear	NULL
factor-kappa	NULL
B	NULL
activation	NULL
,	NULL
monocyte	NULL
chemoattractant	NULL
protein-1	NULL
expression	NULL
,	NULL
and	NULL
macrophage	NULL
infiltration	NULL
in	NULL
a	NULL
rabbit	NULL
model	NULL
of	NULL
early	NULL
accelerated	NULL
atherosclerosis	NULL
.	NULL

Circulation	NULL
95	NULL
:	NULL
1532-1541	NULL
,	NULL
1997	NULL
Ruiz-Ortega	NULL
M	NULL
,	NULL
Bustos	NULL
C	NULL
,	NULL
Hernandez-Presa	NULL
MA	NULL
,	NULL
Lorenzo	NULL
O	NULL
,	NULL
Plaza	NULL
JJ	NULL
,	NULL
Egido	NULL
J	NULL
:	NULL
Angiotensin	NULL
II	NULL
participates	NULL
in	NULL
mononuclear	NULL
cell	NULL
recruitment	NULL
in	NULL
experimental	NULL
immune	NULL
complex	NULL
nephritis	NULL
through	NULL
nuclear	NULL
factor-kappa	NULL
B	NULL
activation	NULL
and	NULL
monocyte	NULL
chemoattractant	NULL
protein-1	NULL
synthesis	NULL
.	NULL

J	NULL
Immunol	NULL
161	NULL
:	NULL
430-439	NULL
,	NULL
1998	NULL
Morrissey	NULL
JJ	NULL
,	NULL
Klahr	NULL
S	NULL
:	NULL
Enalapril	NULL
decreases	NULL
nuclear	NULL
factor	NULL
kappa	NULL
B	NULL
activation	NULL
in	NULL
the	NULL
kidney	NULL
with	NULL
ureteral	NULL
obstruction	NULL
.	NULL

Kidney	NULL
Int	NULL
52	NULL
:	NULL
926-933	NULL
,	NULL
1997	NULL

